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Introduction 
 
A eukaryotic cell is a busy microcosmos. Proteins must be transported to specific 
locations. Organelles have to be positioned at their correct intracellular location and the 
polarity of the cell has to be maintained. The plasma membrane needs to be mechanically 
supported and the overall shape of the cell has to be regulated. But when it is time for the 
cell to divide, the well cared-for organization is lost and has to be rearranged rapidly. The 
previously duplicated chromosomes need to be separated from each other and must be 
segregated to the future daughter cells, and once time has come for them to break their 
physical linkages, their plasma membranes have to be divided. To carry out all these 
tasks, the cell is crucially dependent on a complex system of networked filaments called 
the cytoskeleton. 
 
The cytoskeleton 
 
The cytoskeleton is composed of three different protein families, each of them forming 
filamentous structures. These cytoskeletal filament systems are assembled from protein 
subunits and hence are dynamic structures with their dynamics being defined by the rates 
of polymerization and depolymerization. This feature also enables them to react rapidly 
and energy-efficiently to any change occuring to the cell or its surrounding. Each one of 
the three systems fulfills different functions within the cell but at the same time is 
dependent on cooperation with the other filament systems. 
 
The three major cytoskeletal components are the actin microfilaments, the intermediate 
filaments and the microtubules (Alberts, 2008). 
 
Actin filaments 
 
Actin filaments are composed of actin monomers - globular polypeptides that assemble 
head to tail to form a polarized noncovalently bound polymer. Two actin filaments built 
in this fashion, intertwine to create a double-helical structure (Figure 1). Actin filaments 
are able to form linear bundles, so called actin stress fibers – (O'Neill, 2009) , two 
dimensional meshworks, called lamellipodia (Bugyi and Carlier, 2010), or three 
dimensional gels, as can be found in the cell cortex. Each actin subunit has the ability to 
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tightly bind ATP molecules and hydrolyze them. This enzymatic activity is very low in 
the free (G-actin) form and strongly increases when in the filamentous form (F-actin). 
Together with the fact that one end of the actin filament (the plus end) binds new subunits 
more readily, this leads to a phenomenon known as treadmilling (Wegner, 1976), 
whereby this chemical kinetic view of polymerization dynamics is gaining complexity 
with the observation that structural states of the polymer itself also influence the 
polymerization dynamics. This theory is called structural plasticity (Kueh and Mitchison, 
2009). 
 
Actin is distributed throughout the cell, but is highly concentrated at the periphery. The 
initiation of the actin polymerization, called nucleation, takes place near the plasma 
membrane. Actin’s major roles in the cell are: regulating the cell’s shape; cell migration, 
endocytosis, vesicle trafficking, and to generate contraction forces such as in the 
sarcomers of skeletal muscle or in the contractile ring during cytokinesis (Goley and 
Welch, 2006). Several accessory proteins, binding to actin, have been described. These 
proteins are able to influence actin polymerisation dynamics, regulate bundling of actin 
filaments and enable the microfilament system to form structures like lamellipodia (for 
review see Lee and Dominguez, 2010). The actin related protein complex (ARP complex) 
is known to control nucleation of actin filaments in branched actin networks (Ma et al., 
1998). Proteins like thymosin and profilin influence actin polymerisation by binding to 
free actin subunits (Yarmola and Bubb, 2004). Other proteins, like gelsolins are able to 
sever actin filaments, thus causing restructuring of the filament system (McGough et al., 
2003). Filamin cross-links actin filaments into a three dimensional network which has the 
physical properties of a gel (Tseng et al., 2004). In contrast α-actinin packs actin 
filaments into tight contractile bundles containing bipolar arrays of myosin II, called 
stress fibers (Otto, 1994; Naumanen et al., 2008) . Moreover, other proteins link actin to 
membranous junctional complexes. Motorproteins of the myosin superfamily bind to 
actin filaments and undergo conformational changes upon binding and hydrolsis of ATP 
molecules. In this fashion they move along the actin filament and are integral parts of 
contractile actin bundles (Inoue et al., 1979). These, and many more accessory proteins 
work together to orchestrate the highly regulated events involved in cell contraction and 
migration. Often, cytoskeletal rearrangements are induced by extracellular signals. These 
signals converge on the Rho protein family of monomeric GTPases, which themselves 
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trigger signaling cascades leading to major actin rearrangements (Ridley et al., 1999), 
such as the formation of stress fibers and the consequent cell contractility. 
 
 
 
Figure 1. Depiction of an actin monomer and actin filament. (A) The actin monomer 
has a nucleotide (ATP or ADP) bound in a cleft in the center of the molecule. (B) 
Arrangements of monomers in an actin filament. Two protofilaments wind around each 
other to form a helical structure, with a twist repeating every 37 nm. Subunits in the helix 
have the same orientation. (C) Electron micrographs of negatively stained actin filaments. 
(modified from Alberts, 2008) 
 
Microtubules 
 
Microtubules (MTs) are dynamic filamentous polymers. MTs have various functions 
inside the cell. They direct intracellular transport, determine the position of organelles 
and are involved in chromosome segregation, morphogenesis and directed migration.  
MTs are formed from globular heterodimers which are built from two different tubulin 
monomers, α- and ß-tubulin. 13 protofilaments consisting of tubulin heterodimers 
arranged in linear fashion assemble laterally and form a stiff hollow tube with an outer 
diameter of approximately 25 nm. The microtubules have a distinct structural polarity 
with α-tubulin on one end and ß-tubulin on the other (Figure 2). Like actin monomers, the 
tubulin monomers are able to bind and hydrolyze nucleotide triphosphates. Actin 
monomers bind ATP molecules, whereas tubulin binds and hydrolyzes GTP. Thus the 
treadmilling phenomenon can also be observed in microtubules. Another dynamic 
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property of microtubules is called dynamic instability. When the concentration of free 
tubulin subunits falls under a critical concentration, the GTP hydrolysis can proceed more 
rapidly than the addition of GTP-tubulin dimers at the growing plus end of the 
microtubule. Then the protective GTP cap is lost and rapid shrinking of the filament 
occurs, which is called catastrophe. Eventually the MT is rescued when the conc-
entration of free tubulin rises and the GTP cap is restored (Desai and Mitchison, 1997). 
The (slower growing) minus end of microtubules is anchored at microtubule-organizing 
centres (MTOC). Often cells possess only one MTOC which is then called the 
centrosome. The MT plus ends are free for the addition of tubulin subunits and grow to 
the periphery of the cell. To fulfill their numerous functions, microtubules are dependent 
on specific microtubule associated proteins (MAPs) that regulate microtubule dynamics 
and their interaction with other proteins (Mandelkow and Mandelkow, 1995). MAPs like 
tau or MAP2 can bind to microtubules and thereby stabilize them. These MAPs have, in 
addition to their binding domain, another domain projecting away from the microtubule 
that can bind to a second microtubule, thus crosslinking the two fibers (Weisshaar and 
Matus, 1993). The length of the projecting arm determines the packing density of the MT 
bundles. There are also proteins binding to microtubules that cause destabilization, like 
members of the kinesin superfamily (Waters and Salmon, 1996). Moreover, capping 
proteins like EB1 can help to position microtubules to their correct intracellular locations 
(Muhua et al., 1998).  
 
Motor proteins represent a fascinating group of cytoskeletal proteins. They use energy 
released by ATP hydrolysis for repeated cycles of conformational change to move 
alongside cytoskeletal filaments (for review see Wade, 2009). Microtubule binding 
motorproteins comprise two superfamilies, the kinesins and the dyneins. Most kinesins 
walk towards the plus end of the microtubule. They are involved in mitotic and meiotic 
spindle formation and chromosome separation during cell division. Dyneins are unrelated 
to kinesins and most of them move towards the minus end of microtubules. They are 
important for vesicle trafficking, localization of the Golgi apparatus and drive the beating 
of cilia and flagella (Mallik and Gross, 2004). 
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Figure 2. The structure of a microtubule and its subunit. (A) The subunit of a 
microtubule filament is a tightly bound α- and ß-tubulin heterodimer. The bound GTP 
nucleotides are shown in red. The GTP in α-tubulin is a tightly bound, integral part of the 
molecule that, unlike the GTP in ß-tubulin, is not involved in polymerization dynamics. 
(B) A single protofilament is built from tubulin heterodimers (= MT subunits) that are 
arranged head to tail. (C) The microtubule is a stiff hollow tube formed from 13 
protofilaments that are aligned in parallel. (D) Electron micrograph of a microtubule. (E) 
Electron micrograph of a microtubule cross section, showing 13 protofilaments. 
(modified from Alberts, 2008) 
 
Intermediate filaments 
 
Intermediate filaments (IFs) are ropelike structures, approximately 10 nm in diameter. IFs 
are built from a heterogeneous group of proteins. The individual IF proteins are grouped 
into six types according to their amino acid sequences, net acidic charge and secondary 
structure predictions. Acidic and basic IF proteins are grouped as Type I and II. 
According to their mode of assembly, these two types, which include all keratins, can be 
grouped as assembly group 1. Assembly group 2 consists of type III and IV IF proteins 
and constitute the largest group of IF proteins. Desmin, paranemin, synemin, peripherin, 
GFAP and vimentin are grouped into type III, whereas α-internexin, the neurofilament 
proteins, nestin and syncollin are grouped into type IV. The nuclear lamins are grouped 
into type V and constitute the assembly group 3. Type VI IF proteins are only found in 
lens cells and have not been classified into an assembly group to date. Although they 
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fulfill various functions in different cell types, and despite their heterogeneity, all IF 
proteins share high amounts of structural similarities. They are all built from  a highly 
conserved α-helical rod domain which is flanked by variable N-terminal head and C-
terminal tail domains (Eriksson et al., 2009) (Figure 3). 
 
Figure 3. Intermediate filament classification. (A) The basic tripartite domain structure 
common to all IF proteins. A highly conserved α-helical rod domain is flanked by 
variable N- and C-terminal structures. (B) Based on the rod domain amino acid 
sequences, net acidic charge and secondary structure predictions, cytoskeletal IF proteins 
were grouped in four sequence homology classes (types I-IV). Nuclear IFs make another 
group (V). Group VI IFs are very specialized intermediate filaments only found in the 
lens of the eye. (modified from Eriksson et al., 2009) 
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Cellular organization of intermediate filaments 
The IF network system consists of two individual networks. One, being located inside the 
nucleus, is attached to the nuclear pores, the inner nuclear membrane and chromatin. The 
other system, being cytoplasmic, connects intercellular junctional complexes with the 
outer nuclear envelope. Additionally, the cytoplasmic IF system is interlinked with the 
microtubule and the actin filament system. Interactions with the junctional adhesive 
complexes like desmosomes or hemidesmosomes and the other filament systems are 
mediated by a group of proteins called “plakins” (discussed below). The IF system also 
interacts with organelles like the Golgi apparatus, mitochondria, endosomes and 
lysosomes (Toivola et al., 2005; Kim and Coulombe, 2007). The nuclear and the 
cytoplasmic IF systems are interlinked by proteins of the outer nuclear membrane. Thus a 
mechanical continuum reaching from the extracellular matrix (ECM) to the nucleus exists 
inside a cell. 
 
Intermediate filament assembly 
To assemble into ropelike structures, two IF monomers align in parallel and in register to 
form a coiled coil dimer (Herrmann et al., 2007). One IF dimer, representing the basic 
building block of IFs, then lines up side by side with another, thus creating a staggered 
tetramer of antiparallel coiled-coil dimers. The tetramer is the soluble subunit form of 
IFS. When eight tetramers are packed together in a helical array, a robust ropelike 
filament is formed. (Herrmann et al., 2007). As a consequence of the antiparallel 
association of the dimers, intermediate filaments have no intrinsic polarity.  
Intermediate filament assembly is independent of nucleotide hydrolysis, but remodeling 
and structural performance of IFs in vivo is dependent on kinases, phosphatases and 
chaperones (Green et al., 2005).  
 
Intermediate filaments and disease 
Over 40 genetically determined diseases are known today that are caused by mutations in 
IF-encoding genes (Fuchs and Cleveland, 1998; Irvine and McLean, 1999; Omary et al., 
2004; Kim and Coulombe, 2007). Best characterized, is a disease, caused by mutations in 
keratin 5 or keratin 14 called epidermolysis bullosa simplex (EBS). EBS is a severe skin 
disease in which the basal keratinocytes layer of the epidermis is easily detached from the 
dermis when the skin is exposed to physical stress. (Bonifas et al., 1991; Coulombe et al., 
1991; Lane et al., 1992). At least 13 mutations in laminin A that cause human diseases 
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have been described. Affected patients show symptoms including muscular dystrophies 
and premature aging (Bonne et al., 1999; Liu and Zhou, 2008). Mutations in desmin and 
GFAP were also described (Li et al., 2002; Goldfarb et al., 2004), and have been shown 
to cause muscular dystrophies, cardiomyopathies and a neuronal disease called Alexander 
disease respectively. 
 
The plakin/cytoskeletal linker protein family 
 
Plakins are large multidomain proteins that crosslink cytoskeletal filaments or link them 
to junctional complexes (Sonnenberg and Liem, 2007). They were first discovered in 
epithelial cells, where they connect IFs to desmosomes and hemidesmosomes (for review 
see Ruhrberg and Watt, 1997). The first plakin protein identified was named 
desmoplakin, due to the plaque like appearance of these junctional complexes (Mueller 
and Franke, 1983). Owing to the capacity of plakin proteins to link two or more 
cytoskeletal networks and the fact that most plakins do not localize in a plaque like 
pattern, these proteins have also been called cytolinkers (Wiche, 1998).  
 
To date, seven members of the cytoskeletal linker protein family have been characterized 
in mammals (Figure 4): desmoplakin, envoplakin, periplakin, bullous pemphigoid antigen 
1 (BPAG1), microtubule actin cross-linking factor 1 (MACF1) - also referred to as ACF7 
-  epiplakin and plectin  (reviewed in Jefferson et al., 2004). Plakins are built from 
combinations of specific domains. A plakin domain, built by several spectrin repeats 
interrupted by an SH3 domain, is common to all cytoskeletal linkers with the exception 
of epiplakin. Additionally, according to specific functions of the individual proteins they 
possess domains that bind to actin (ABD), microtubules (GAR and GSR-containing 
domain) and intermediate filaments (PRD and linker region) (Leung et al., 2002). It is 
noteworthy that in plectin the intermediate filament binding occurs not at the PRDs 
themselves but in a linker region between the PRDs. Furthermore microtubules do not 
bind to the GAR and GSR-containing domains in plectin. The PRD is composed of 
varying numbers of repeating unit subdomains, termed A and B and C, depending on 
their degree of sequence similarity to each other (Leung et al., 2002). Epithelial 
cytoskeletal linker proteins possess a coiled-coil spectrin repeat-containing rod that 
enables them to form dimers (Janda et al., 2001).  
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Figure 4. Schematic illustration of the plakin (cytolinker) family members and some 
of their splice variants. (A) The epithelial plakins (names highlighted with asterisks) 
display a characteristic tripartite structure (with the noteable exception of epiplakin) with 
a globular plakin domain at the amino terminus (purple), a central coiled-coil rod domain 
(yellow) and a variable number of plakin-repeat domains (PRDs) at the carboxyl terminus 
(orange); PRDs are grouped into three classes termed A, B and C, and these domains are 
connected by linkers that can also harbor plakin repeat (PR)-like motifs (brown). In the 
spectraplakins, the central coiled-coil rod domain that is found in the epithelial plakins is 
replaced by numerous spectrin repeats (green). The number of spectrin repeats and PRs 
vary between different plakins. (B) Schematic figure showing all important domains 
common to plakins in detail. The known function of each domain is indicated above the 
domains. 
GAR, GAS2 related; GSR repeats, glycine-serine-arginine repeats; calponin-homology 
domain, CH. (modified from Jefferson et al., 2004) 
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Cytoskeletal linker proteins are mostly expressed in tissues that have to withstand severe 
mechanical stress, such as epithelia and skeletal muscle cells (Leung et al., 2002). There 
they crosslink cytoskeletal filaments and also connect them to membrane complexes. 
Hence it is no surprise that most pathological situations resulting from dysfunction of 
cytoskeletal linker proteins lead to disorders involving tissue fragility (for review see 
Sonnenberg and Liem, 2007). 
 
Plectin 
 
Pectin is a large cytoskeletal protein of approximately 500 kDa that is abundantly 
expressed in a wide variety of mammalian tissues and cell types (Wiche, 1989). Its 
unique combination of protein domains allows plectin to bind to all three major 
cytoskeletal filament systems; actin filaments, IFs and microtubules. Additionally plectin 
can bind to various plasma membrane-associated cytoskeleton junctional complexes 
(Pytela and Wiche, 1980; Koszka et al., 1985; Foisner et al., 1988; Andrä et al., 1998; 
Wiche, 1998), thus making it the most versatile cytoskeletal linker protein known to date. 
 
Plectin consists of  globular N- and C-terminal domains which are separated from each 
other by a 200 nm long α-helical rod domain (Figure 5). This tripartite structure is shared 
with other plakin family members except for envoplakin, periplakin and epiplakin. The C 
terminus is encoded by a single huge exon (exon 32). It comprises six plakin repeat 
domains (PRD), which all contain a core region made of a 19 amino acid motif that is 
tandemly repeated (Wiche et al., 1991). Linker regions between the repeats are believed 
to form loop-like structures that are susceptible for interactions with other proteins. 
Plectin’s IF binding site resides in the linker region between PRD 5 and 6 (Nikolic et al., 
1996). Among proteins that were identified as capable to bind to this site are vimentin 
(Foisner et al., 1988), cyto-keratins (Rezniczek et al., 1998), desmin (Reipert et al., 
1999), neurofilaments, and GFAP (Foisner et al., 1988). Additionally integrin β4 was 
shown to also interact with the C terminus (Rezniczek et al., 1998). Further interaction 
partners at this site are RACK1 (Osmanagic-Myers and Wiche, 2004) and AMPK 
(Gregor et al., 2006). 
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Figure 5. Schematic illustration of plectin’s binding domains. Like most plakins, 
plectin has a tripartite structure which comprises a central rod domain (ROD), flanked by 
globular C- (GC) and N-terminal (GN) domains. The N-terminal structure contains the 
actin-binding domain (ABD) and a plakin domain, which is formed of eight spectrin 
repeats interrupted by a SH3-like domain. The C terminus is built from six homologous 
repeat domains (PRD) interrupted by linker regions. The N and the C termini both 
contain multiple binding sites for other proteins. The intermediate filament binding 
domain (IFBD) is located in the linker region between PRD 5 and 6. Interacting proteins 
are listed and defined binding regions are indicated by black bars. Coding exons are 
shown at the bottom. 
 
 
The rigid α-helical rod is able to form coiled-coil dimers with a second plectin molecule. 
Being 200 nm large, the rod is perfectly suited to act as a molecular spacer between 
different cytoskeletal networks (Foisner and Wiche, 1987).  
 
The N-terminal domain of plectin contains a highly conserved actin-binding domain 
(ABD), which consists of a pair of calponin-homology (CH) subdomains. This domain 
does not only interact with actin, but also with vimentin, integrin β4, utrophin, nesprin 3α 
and dystrophin (Seifert et al., 1992; Rezniczek et al., 1998; Sevcik et al., 2004; 
Wilhelmsen et al., 2005; Rezniczek et al., 2007). Another feature of the globular N-
terminal domain is a plakin domain. It consists of several spectrin repeats, interrupted by 
an SH3 domain.  
 
In addition to its stabilizing and connecting features, plectin was shown to serve as a 
scaffolding protein for signaling molecules. Again plectin showed to be extremely 
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versatile. Plectin’s size and the multidomain structure seem ideally suited for this purpose 
(Andrä et al., 1998; Osmanagic-Myers and Wiche, 2004; Osmanagic-Myers et al., 2006). 
 
Plectin shows an unusual complex transcript diversity. 14 alternatively spliced first 
exons, 11 of them directly splicing into exon 2 were identified (Fuchs et al., 1999). The 
11 plectin isoforms thus generated differ in their respective tissue expression patterns, 
protein stability, intracellular localization and specific functions (Rezniczek et al., 2003; 
Rezniczek et al., 2007; Hijikata et al., 2008; Winter et al., 2008; Kostan et al., 2009). In 
some cases two additional exons (2α and 3α) are optionally spliced into the ABD-
encoding sequence, thereby creating fine-tuned acting-binding domains with different 
binding affinities for actin (Fuchs et al., 1999). In addition, plectin isoforms lacking exon 
31, which encodes the rod domain, are expressed in various tissues (Elliott et al., 1997). 
The functions of these rodless-plectin isoforms are not known to date. 
 
Plectin in disease 
Plectin was originally believed to protect cells against mechanical stress. When it was 
shown that mutations in the plectin gene caused EBS–MD (an autosomal recessive 
disease characterized by skin blistering combined with muscular dystrophy) (Chavanas et 
al., 1996; Gache et al., 1996; McLean et al., 1996; Pulkkinen et al., 1996; Smith et al., 
1996), EBS with pyloric atresia (an autosomal recessive disease variant that manifests 
with severe neonatal skin blistering and gastric abnormalities) (for review see Pfendner 
and Uitto, 2005) or epidermolysis bullosa simplex (EBS)–Ogna (an autosomal dominant 
skin blistering disease) (Koss-Harnes et al., 1997; Koss-Harnes et al., 2002). Intriguingly, 
for some EBS–MD patients signs of neurodegenerative disorders (cerebral and cerebellar 
atrophy) have been reported (Smith et al., 1996; Schröder et al., 2002). A patient 
suffering from EBS–MD showed degenerative signs, which were found in intramuscular 
myelinated nerves (Bauer et al., 2001). More recently, plectin was shown to be 
implicated in Alexander disease, a rare pathological disorder, which is caused by 
mutations in glial fibrillary acidic protein (GFAP) (Tian et al., 2006). In addition 
upregulation of plectin expression during astrocyte activation parallels the increase of 
GFAP expression and could thus be a general feature of reactive gliosis (Lie et al., 1998; 
Kalman and Szabo, 2000). Lately, cases of patients with mutations in the sequence 
encoding the plectin isoforms 1f were reported (Gundesli et al., 2010). These patients 
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suffered from limb-girdle muscular dystrophy. Probably due to the loss of plectin 1f 
scaffolding at the sarcolemma of skeletal muscle (Rezniczek et al., 2007). 
 
Plectin mouse models 
To study the molecular mechanisms behind these diseases and plectin’s other functions, 
plectin-null mice were generated by targeted gene deletion (Andrä et al., 1997). Plectin-
deficient mice died a few days after birth due to severe skin blisterings. They also 
developed muscular dystrophies in skeletal and heart muscle (Andrä et al., 1997). 
Impaired food uptake because of blistering on the palates proved to be the reason for their 
mortality (Ackerl et al., 2007). Striated muscle-specific conditional plectin knock-out 
mice subsequently generated showed progressive degenerative alterations in striated 
muscle, including aggregation and partial loss of IF networks, detachment of the 
contractile apparatus from the sarcolemma, profound changes in myofiber costameric 
cytoarchitecture, and decreased mitochondrial number and function (Konieczny et al., 
2008). To study the function of individual plectin isoforms, specific knockout mice were 
engineered for plectin 1 – where primary fibroblasts and leukocytes showed reduced 
migratory potential (Abrahamsberg et al., 2005), plectin 1b – where primary fibroblasts 
and myoblasts showed altered mitochondrial morphology (Winter et al., 2008) and 
plectin 1d, which links the IF network to Z-disks and where its loss leads to muscular 
dystrophy (Konieczny et al., 2008). Plectin 1c-specific KO mice revealed a role of this 
isoform in motor nerve conduction (Fuchs et al., 2009). 
The peripheral nervous system 
 
The peripheral nervous system (PNS) comprises nerves and ganglia outside the central 
nervous system (CNS). It can be divided further into the somatic and the autonomic 
nervous system. The main role of the PNS is to relay information in the form of electric 
currents from the CNS to organs and muscles. For this purpose, there are two types of 
neurons in the PNS. The motor neurons (or efferent neurons) relay signals away from the 
CNS towards the periphery, and the sensory neurons (or afferent neurons) relay signals, 
received in the periphery, to the CNS. Unlike the CNS, the PNS is not protected by a 
cage of bone (e.g. the skull and the vertebra) and thus is susceptible to mechanical stress 
and injury. However, similar to CNS the nerves’ axons are surrounded by glia cells that 
fulfill three main functions: i) electrically isolating the axon to enable the saltatory move 
conduction; ii) connecting the axons to the surrounding basal membrane, thus stabilizing 
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the nerves and ensuring their protection from mechanical stress; iii) transducing signals 
from the ECM to influence morphology and differentiation of the nerves. In the CNS, the 
glia cells consist of astrocytes, oligodendrocytes and microglia. In the PNS there is only a 
single cell type called the Schwann Cells (SCs). 
 
Myelinating SCs 
 
Myelinated axons are a fundamental adaptation of vertebrates to guarantee a faster and 
more efficient signal transduction. Upon differentiation SCs wrap around the axons and 
electrically isolate them by the synthesis of myelin, a biomembrane which is especially 
rich in lipids. Specific regions of the axons are left uncovered which are called nodes of 
Ranvier (for review see Salzer et al., 2008). There the action potential, originally 
generated at the axon initial segment (AIS), is regenerated, resulting in a more rapid and 
energy efficient propagation of signals than observed in unmyelinated fibers (Salzer, 
1997). Named after the german physiologist Theodor Schwann, the SC is the glial cell 
type that accounts for the myelination of axons in the PNS (Figure 6). The myelinating 
SCs are highly specialized cells which are radially and longitudinally polarized in their 
differentiated state (for reviews see Poliak and Peles, 2003; Salzer, 2003). The radial 
polarization is reflected by the fact that myelinating SCs possess two distinct plasma 
membrane surfaces: one that faces the axon (axonal membrane) and the other facing the 
surrounding basal membrane (abaxonal membrane). The two membrane surfaces differ in 
their protein composition and their domain organization. The inner, adaxonal, membrane 
and the underlying axolemma form strictly organized domains including the nodes of 
Ranvier, paranodes, juxtaparanodes and the internodes.  
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Figure 6. Schematic depiction of myelinating axons. (A) SCs enwrap axons in the 
PNS, thus forming the myelin sheath and electrically isolating the nerve along the 
internodes, leaving only the nodes of Ranvier exposed to the basal lamina. The action 
potential is only regenerated at the nodes (depicted in red). In contrast to 
oligodendrocytes of the CNS, SCs wrap around one single axon. (B) A longitudinal 
section through a SC-axon unit illustrating the domain organization of myelinated SCs. 
Through crosstalk with the SC, the axon becomes structured into nodes, paranodes, 
juxtaparanodes (JXP) and internodes. Microvilli, formed by the abaxonal SC membrane 
are in close contact with the nodes of Ranvier. At the paranode, paranodal loops form 
membrane appositions with the axon called septate like junctions, which are believed to 
create a physical barrier between the node and the paranode. The node of Ranvier is 
directly covered by the basal lamina. (C) A schematic cross section of a myelinated nerve 
fiber showing the two different membrane surfaces. The abaxonal membrane (outer 
mesaxon – OMA) and the adaxonal membrane (inner mesaxon – IMA). (modified from 
Poliak and Peles, 2003) 
 
Hence it is not surprising that the concentration of sodium channels (~1500/µ2) is 25-fold 
higher at the nodes of Ranvier than at the internode (Hille, 2001). The nodes are flanked 
by domains called paranodes. Here the SC membranes form loops (septate like 
junctions), which create a close apposition between SCs and the axonal membranes. 
These structures are thought to create physical barriers between the node and the 
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internode. The juxtaparanodes, a domain, that is not well studied and understood to date, 
separates the paranodes and the internodes. At the internodes, by far the biggest domain 
in the myelinated nerve fiber, the axolemma and the adaxonal SC membrane are 
separated by a periaxonal space of 15 nm. 
 
In addition to the domain organization on the axon-facing side of the SC, the abaxonal 
side of the cell is also compartmentalized. Almost 80 years ago Ramón y Cajal (1933) 
described channel like structures at the outermost cytoplasm in SCs. He argued that these 
cytoplasmic tunnels, which where called after him Cajal bands, had nutritive functions. 
The Cajal bands represent the cytoplasm between the abaxonal SC membrane and the 
underlying myelin. These cytoplasmic channels are interspersed by regions where the 
plasma membrane forms tight appositions with the myelin. Thus the cytoplasm forms 
longitudinal Cajal bands and radial trabeculae. 
 
  
 
Figure 7. Cajal bands and appositions. (A) A schematic depiction of a myelinated 
axon. The SC wraps around the axon, forming regions of compact myelin where the 
myelin is in close apposition to the abaxonal membrane. Other regions, called Cajal 
bands represent cytosolic longitudinal tunnels which are linked by transverse trabeculae 
(modified from Nature publishing group). (B) Immunofluorescent staining of teased 
nerve fibers, featuring a node of Ranvier. A staining of vimentin shows its localization in 
Cajal bands (green). Appositions are shown with a staining for DRP2 (red). 
 
Schmidt-Lanterman incisures present funnel-shaped interruptions in the compact myelin, 
creating connections between the cytosol of the SC domain that is apposing the axon and 
the region that is apposing the basal lamina. Compartmentalization of the SCs is crucially 
dependent on interactions and crosstalk with the ECM, which is mediated by 
transmembrane ECM-receptor proteins. 
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Abaxonal SC receptor complexes 
Big advancements have been made in the recent years in understanding on the molecular 
level what Ramón y Cajal had observed 100 years ago. Myelinating SCs differentiate 
from immature SCs upon signals derived from axons. In response the SCs organize the 
compartmentalization of the axons, as already described above. To fulfill their various 
functions the myelinating SCs need to hold close contact to the surrounding basal 
membrane through abaxonal SC ECM-receptor complexes. The basal lamina surrounding 
the myelinated nerves is composed of collagen IV, fibronectin, heparin sulfate 
proteoglycan, and laminins. Experiments designed to find out which of the major basal 
lamina components promotes myelination by SCs demonstrated that laminins are 
necessary and sufficient for the differentiation of SCs to become myelinating SCs 
(Eldridge et al., 1989). An intact ECM was shown to be necessary for providing 
mechanical stability during myelination (Podratz et al., 2001). Four laminin 211 receptors 
in the abaxonal SC membrane have been described: integrin α7β1, integrin α6β4, integrin 
α6β1 and the dystrophin-glycoprotein complex (DGC). Integrin α6β1 is crucial for the 
development of the PNS and axonal sorting during development (Previtali et al., 2003b). 
The other three laminin 211 receptors are expressed postnatally. Integrin α6β4 and the 
DGC are expressed right before myelination, whereas integrin α7β1, which is dispensable 
for development and myelination of the peripheral nerve, is expressed during myelination 
(Previtali et al., 2003a; Previtali et al., 2003b).  
 
Integrin α6β4 is expressed during myelination after axonal contact has been established 
and subsequently localizes at the abaxonal SC membrane apposing the basal lamina 
(Feltri et al., 1994). The complex was shown to be dispensable for development, 
myelination, maturation or regeneration of peripheral nerves. However in older mice 
lacking integrin α6β4 an increased number of axonal myelin infoldings was observed 
(Nodari et al., 2008). In line with the observation that the expression of integrin α6β4 
increases during adulthood this indicated a similar role for SC-specific integrin α6β4 as in 
skin: mechanical stabilization of the cells via stable anchorage to the basal lamina 
(Nodari et al., 2008). Integrin β4 has a uniquely long cytoplasmic tail which facilitates 
multiple interactions. In SCs integrin α6β4 is associated with another transmembrane 
protein called peripheral myelin protein 22, whose alterations account for the most 
common demyelinating hereditary neuropathy, the Charcot-Marie-Tooth disease (Roa et 
al., 1993). 
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The DGC (also termed dystroglycan complex) is a well described receptor complex. At 
its heart there is a heterodimeric adhesion receptor that consists of two glycoproteins 
which are transcribed from one gene and are then posttranslationally cleaved. The 
extracellular protein that mediates linkage with the basal lamina is called α-dystroglycan. 
It is subject to extensive O- and N-linked modifications. α-dystroglycan is bound, 
noncovalently to the transmembrane protein of the receptor complex called β-
dystroglycan. (for reviews see Bozzi et al., 2009b; Moore and Winder, 2010). The DGC 
is an incredibly versatile receptor with functions ranging from a sarcolemmal stabilizer in 
skeletal muscle to roles in embryogenesis, cancer progression and cell signaling (Spence 
et al., 2004; Anderson et al., 2007; Cross et al., 2008). Like integrin α6β4, dystroglycan is 
expressed after birth but before the onset of myelination and becomes polarized to the 
abaxonal membrane upon start of myelination. (Previtali et al., 2003b). Specific ablation 
of dystroglycan in SCs leads to reduced nerve conduction velocity and nodal changes 
including disorganized microvilli and reduced sodium channel clustering. Additionally, 
similar to SC-specific integrin α6β4 knockout mice, more myelin infoldings were 
detected in DG-KO mice (Saito et al., 2003). 
 
In skeletal muscle, β-dystroglycan is intracellularly bound to dystrophin and utrophin. 
These two proteins link the laminin receptor to filamentous actin (Rybakova et al., 2000). 
In addition β-dystroglycan was shown to bind plectin, thus being connected to actin 
and/or intermediate filaments (Rezniczek et al., 2007). In myelinating SCs no full length 
dystrophin is present, but an alternatively spliced  N-terminal isoform (DP116) is 
expressed (Byers et al., 1993). DP116 contains the dystroglycan binding domain but is 
lacking the actin binding part. On the other hand, utrophin is expressed in SCs in its 
original form, thus being likely able to mediate binding to filamentous actin. This 
laminin-211-dystroglycan-utrophin axis is only present in cytoplasmic compartments 
(Cajal bands) of the myelinating SCs (Court et al., 2009). It is necessary for 
compartmentalization and elongation of myelin segments (Court et al., 2009). Another 
dystroglycan complex was shown to be localized to the appositions, which are 
segmenting the Cajal band. In this complex α- and β-dystroglycan interact with the 
dystrophin-related protein 2 (DRP2) to bind to L-periaxin. DRP 2 is the only protein 
known to date that is solely expressed in appositions (Sherman et al., 2001). Figure 8 
gives an overview of the abaxonal SC laminin 211 receptors. 
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Figure 8. Abaxonal SC membrane laminin receptor complexes. (A) A simplified 
illustration of laminin 211 receptors found in the abaxonal SC membrane (ACM) of Cajal 
bands (cytoplasmic regions). Depicted are the dystrophin-glycoprotein complex (DGC), 
integrin α7β1 and integrin α6β4. In the DGC, dystroglycan can be associated with 
utrophin and DP116. Utrophin can bind to filamentous actin (f-actin) thus interlinking the 
ECM via the dystroglycans with the actin cytoskeleton. In contrast to utrophin, DP116 
lacks the actin-binding domain. The sarcoglycans, a protein complex consisting of four 
sarcoglycan subunits that is associated with ß-dystroglycan, is also shown. Integrin α6β4 
is associated with PMP22. Plectin could form interactions with all the transmembrane 
ECM-receptors shown here, as well as with utrophin, DP116 and the intermediate 
filament system. (B) The DGC is also found in appositions where the abaxonal SC 
membrane is directly apposing the compact myelin, leaving no space for the cytoplasm. 
There, β-dystroglycan is binding to the dystrophin-related protein 2 (DRP2) which binds 
to periaxin. Periaxin forms dimers via its PDZ domain.  
(CP – cytoplasm of Cajal bands) 
 
Intriguingly, plectin was shown to directly bind to integrin β4, β-dystroglycan and 
integrin α7 (unpublished data) in other tissues (Rezniczek et al., 1998; Rezniczek et al., 
2007), thus making it a likely candidate for important roles in the SC. 
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Aims of the thesis 
 
The goal of this thesis was to investigate if plectin forms ECM-IF axes by binding to 
laminin-receptor complexes of the abaxonal SC membrane. To investigate this possibility 
I first wanted to identify which plectin isoforms are expressed in SCs of sciatic nerve, by 
using immunofluorescence microscopy and immunoblotting analyses. The next goal was 
to find possible interactions of plectin with the laminin 211 receptors by using 
immunofluorescence microscopy, co-immunoprecipitation and overlay assays. To further 
investigate plectin’s role in association with the laminin-receptors and to assess 
consequences of a loss of plectin in SCs, I made use of the recently established P0-Cre/ 
plectin cKO mouse line. Possible alterations in the expression levels of cytoskeletal 
proteins as well as possible alterations in the stability of the laminin receptor complexes 
were to be tested. Furthermore the effect of plectin’s absence on the 
compartmentalization of myelinating SCs and the differentiation into distinct domains of 
myelinated axons should be investigated. Ultimately primary SCs were to be isolated 
from wild-type and P0-Cre/cKO mice and analyzed for phenotypic changes including 
adhesion, proliferation, migration and their capability to react to signaling molecules. 
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Results 
 
1. Identification of the major plectin isoforms expressed in    
sciatic nerves and SCs 
 
Detection of plectin isoforms 1 and 1c on frozen sciatic nerve cross 
sections 
 
Plectin, in particular isoform 1c, has been previously shown to be expressed in SCs in 
situ as well as in cultured SCs ex vivo (Fuchs et al., 2009). However, it remained unclear 
if other isoforms were expressed in SCs as well. Cryo-fixed sciatic nerve cross sections, 
were immunofluorescence labeled, using antibodies specific for plectin isoforms 1 
(Abrahamsberg et al., 2005), 1a (Rezniczek et al., 1998), 1c (Fuchs et al., 2009) and 1f 
(Rezniczek et al., 2007) (Figure 9). In addition, the sections were stained with antibodies 
to the neurofilament medium chain to visualize the axons. Antibodies to plectin isoform 1 
as well as those to plectin 1c produced signals and were found to label the cytoplasm of 
SCs in sciatic nerve cross sections (arrows in Figure 9B,D), whereas antibodies to the 
isoforms 1a and 1f produced only stainings in other cell types (arrowheads in Figure 
9C,E). However, when we stained teased myelinated nerve fibers with antibodies to 
plectin isoform 1f, we observed its expression in nodes of Ranvier and Schmidt-
Lanterman incisures (SLIs) (Figure 9F). The low abundance of the nodes of Ranvier 
explains why no SC-specific plectin 1f staining could be detected in sciatic nerve cross-
sections. 
 
Analysis of plectin isoforms in total cell lysates from sciatic nerve 
and primary SCs 
 
Subsequently, isoform specific antibodies were used to analyze plectin isoform 
expression in total cell lysates derived from sciatic nerve of wild-type mice. In peripheral 
nerves, SCs are present in a differentiated, myelinating state.  However, peripheral nerves 
contain also fibroblasts and blood vessels in addition to SCs, making the interpretation of 
immunoblots of sciatic nerve total cell lysates difficult to interpret.  
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Figure 9. Analysis of plectin isoform expression on frozen sciatic nerve cross 
sections by immunofluorescence microscopy. (A-E) Cryo-fixed sciatic nerve cross 
sections were immunostained using plectin isoform-specific antibodies as indicated. 
Antibodies to the neurofilament medium chain were used to visualize axons. Plectin-
specific immunostaining appears in red, neurofilament medium chain-specific immuno-
staining is shown in green. Expression of plectin 1 and 1c was detected in both SCs and 
axons (B,D), whereas plectin 1a and 1f expression could be detected only in other cell 
types, presumably endoneurial fibroblasts and blood vessels (arrowheads in C,E). Arrows 
depict plectin-specific staining in the cytoplasm of myelinating SCs. Arrowheads show 
plectin staining in cell types other than SCs, such as endoneurial fibroblasts and blood 
vessels. (F) Teased sciatic nerve fibers were immunostained using antibodies to plectin 
1f. Note specific labeling of nodes of Ranvier and of Schmidt-Lanterman incisures. 
 
 
To obtain a plectin isoform expression profile specific for SCs, without background 
signals stemming from endo- and perineuronal fibroblasts, blood vessels, and axons, 
primary SCs were isolated from sciatic nerves derived from wild-type mice. These cells 
were grown in culture for three days and total cell lysates were subsequently prepared. 
Based on assessments using morphologic criteria, such cultures were found to still 
contain some (<5%) endoneurinal fibroblasts. Therefore we also prepared cultures of the 
contaminating endoneurinal fibroblasts (eFs), free of SCs. Total cell lysates from sciatic 
nerve, primary SCs and eFs were subjected to SDS-PAGE and subsequently analyzed by 
immunoblotting. The results of these analyses are shown in Figure 10.  
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Figure 10. Immunoblotting of plectin isoforms 1, 1c and 1f in total cell lysates from 
sciatic nerve and primary SCs. (A) Analysis of sciatic nerve cell lysates using an 
antiserum not discriminating between isoforms (pan-plectin) as well as antibodies to 
plectin isoforms 1, 1a, 1c and 1f. Note that antibodies to plectin isoforms 1, 1c and 1f all 
produced a second band of lower molecular mass, likely representing plectin rodless 
isoforms. Total cell lysates obtained from fibroblasts and keratinocytes (MK +/+ p53 -/- 
Andrä et al., 2003) were used as positive controls. (B) Primary SCs were isolated from 
sciatic nerves of wild-type mice, and kept in culture for three days before preparation of 
total cell lysates for immunoblotting. Antibodies to plectin isoforms 1, 1a, 1c and 1f were 
used. Endoneurial fibroblasts, isolated from the same sciatic nerves were analyzed in 
parallel. Note the presence of a second immunoreactive band of lower molecular mass 
(indicated by asterisks) which was not detected using mAb 10F6. 
 
 
In both, the sciatic nerve and the primary SC total cell lysates, the antibodies to plectin 
isoform 1c generated the most prominent signal, indicating that plectin 1c might be the 
dominant, or at least the strongest expressed isoform in myelinating as well as in 
undifferentiated SCs. However, since nothing is known about the antigen affinities of the 
antibodies used, and also the background signals from cell types other than SCs have to 
be considered, no precise conclusions about relative expression levels of plectin isoforms 
could be made. Antibodies to plectin isoform 1 produced robust signals in both lysates 
albeit they were not as strong as the signals obtained with antibodies to plectin isoform 
1c. Plectin 1f could be detected as well in both lysates, although the intensity of the signal 
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in sciatic nerve total cell lysates was at the lower limit of detection. In neither of the 
lysates, could expression of plectin isoform 1a be detected by immunoblotting. 
Endoneurial fibroblasts were found to express all four plectin isoforms analyzed.  
 
Strikingly, antibodies to plectin isoforms 1, 1c and 1f all produced a second band of 
lower molecular mass in sciatic nerve and primary SC total cell lysates (Figure 10). 
These bands most likely represented the rodless plectin isoforms (Fuchs et al., 1999). To 
verify this, immunoblotting of primary SC total cell lysates was performed using a 
monoclonal antibody (mAb) 10F6 which binds to plectin’s rod domain, and thus can 
detect the full length but not the rodless plectin variant. In fact only the upper, full length 
plectin band was detected on immunoblots using mAb 10F6 (Figure 10B). We also 
observed, that the rodless isoforms seemed to be more prominent in total cell lysates 
derived from primary SCs than in those from sciatic nerve (compare asterisks in Figure 
10A,B).  
 
Immunolocalization of plectin isoforms in primary SCs 
 
To assess the cellular localization of plectin isoforms primary SCs were subjected to 
immunofluorescence microscopy using isoform-specific antibodies to plectin 1, 1a, 1c, 
and 1f. For comparison, anti pan-plectin antiserum was used and cell nuclei were stained 
with Hoechst dye. The anti pan-plectin staining was used to set the laser intensities and 
detection thresholds with which all other images shown in Figure 11 were acquired. 
Using the pan-plectin antiserum, plectin was found to be distributed evenly through the 
cytoplasm of primary SCs (Figure 11A). In contrast, antibodies to plectin 1 produced a 
strong signal which was concentrated around the nucleus (Figure 11B). Like on the 
immunoblots, antibodies to plectin isoform 1c strongly stained primary SCs, but unlike 
plectin 1, plectin 1c was also found in the SCs’ processes (Figure 11C). Again in 
accordance with the immunoblots, the plectin 1f antibody gave a very faint signal on SCs 
(Figure 11E). This could indicate that the plectin 1f-specific signals detected in primary 
SC total cell lysates originated from contaminating fibroblasts. Surprisingly, also 
antibodies to plectin 1a produced immunofluorescence signals (Figure 11D). On 
immunoblots plectin 1a antibodies produced a very strong background staining (data not 
shown). The immunofluorescence signal, likely is unspecific. 
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Figure 11. Immunolocalization of the major isoforms of plectin in primary SCs. 
Primary SC cultures were methanol-fixed and subjected to immunofluorescence 
microscopy using the same set of antibodies as in Figure 10. The plectin signal is shown 
in red, nuclear Hoechst staining is shown in blue. Note the presumably unspecific 
staining of SCs with antibodies to plectin 1a (D). 
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2. Identification of SC-specific plectin interaction partners 
 
As explained in the introduction, three out of four known laminin 211 receptors located 
in the abaxonal SC membrane, are found in the same compartment as plectin in mature 
myelinating SCs, namley integrin α7β1, integrin α6β4 and the DGC. The DRP2 complex 
is exclusively found in SC membrane appositions, a SC compartment where plectin is not 
expressed (Figure 12). Therefore, this complex was excluded from our interaction 
analysis. Due to technical limitations we also did not investigate a potential interaction 
between plectin and integrin α7. Hence, for the analysis of plectin binding partners in 
SCs we focused on integrin α6β4 and the DGC, both of which have been previously 
shown to interact with plectin in other tissues.  
 
 
 
Figure 12. Immunofluorescence microscopy of teased nerve fibers using anti pan-
plectin antibodies (#21). Note staining of Cajal bands (arrows) and their interlinking 
trabeculae (arrowheads). The background staining of sciatic nerve fibers from P0-
Cre/cKO mice was considered unspecific, as previous data had shown that plectin is 
lacking from SCs of P0-Cre/cKO mice (data not shown). 
 
Co-IP of plectin with β-dystroglycan from sciatic nerve homogenates 
 
Rat sciatic nerve homogenates were used to test for the interaction of plectin with the SC-
specific DGC. The homogenates were precleared with protein-G agarose beads to avoid 
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false positive results stemming from proteins unspecifically binding to the beads. The 
pre-cleared supernatant was then incubated overnight with a mixture of two antisera 
recognizing β-dystroglycan (Ilsley et al., 2001). A co-immunoprecipitation (Co-IP) using 
antibodies to GFP was carried out in parallel, using a precleared aliquot of the same 
sciatic nerve homogenate. The precipitated immunocomplex was separated by SDS-
PAGE and tested for the presence of β-dystroglycan and co-precipitated plectin by 
immunoblotting analysis. Figure 13 shows that plectin as well as full length β-
dystroglycan (β-DG 43) and a 30 kDa fragment (β-DG 30) generated by proteolytic 
cleavage of β-dystroglycan, were co-immunoprecipitated with the antisera directed 
against β-dystroglycan. Neither plectin, nor β-dystroglycan could be detected in control 
IPs using an antiserum to GFP. These findings indicated that β-dystroglycan was an 
interaction partner of plectin in SCs. 
 
 
 
 
Figure 13. Immunoblots demonstrating co-precipitation of plectin with β-
dystroglycan. Rat sciatic nerve homogenates were subjected to immunoprecipitation 
experiments using a mixture of two anti-β-dystroglycan antisera as bait antibodies and an 
anti-GFP antiserum as control. Immunoprecipitates were separated on SDS-PAGE and 
subjected to immunoblotting using antibodies to plectin and β-dystroglycan. Note that 
full length β-dystroglycan (β-DG 43), as well as a 30 kDa β-dystroglycan fragment (β-
DG 30) were found in the precipitate. 
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Co-precipitation of vimentin and integrin β4 with plectin in sciatic 
nerve homogenates 
 
To validate the plectin-β-dystroglycan interaction, a second Co-IP experiment was 
performed, this time using an antiserum to plectin (serum #9 Andrä et al., 2003) as bait 
antibodies. Again, rat sciatic nerve homogenates were used as input. Like for the 
dystroglycan IP, a parallel IP with antibodies to GFP as bait antibodies served as negative 
control and should guarantee the specificity of the signal. However, we were unable to 
detect β-dystroglycan in the precipitate (Figure 14A).  
 
When the plectin immunoprecipitate was probed on an immunoblot with antibodies to the 
intermediate filament protein vimentin, a signal could be detected. No vimentin was 
immunoprecipitated with control antibodies (Figure 14A). To validate this interaction and 
possibly map plectin’s binding domain, a blot-overlay experiment was performed. 
Cytoskeletal protein fractions derived from rat sciatic nerves were separated on SDS-
PAGE and subsequently blotted onto a nitrocellulose membrane. The membrane was 
overlaid with his-tagged plectin fragments. Cytoskeletal proteins binding to his-tagged 
plectin fragments were detected by immunoblotting using antibodies to the histidine tags. 
A ~60 kDa protein binding to the C-terminal plectin fragment was detected, which might 
likely be vimentin (Figure 14C). 
 
To test if integrin α6β4, another abaxonal SC membrane laminin 211 receptor complex, 
interacted with plectin, rat sciatic nerve homogenates were used for immunoprecipitation 
experiments using an antiserum to plectin (serum #9) as bait. The resulting immuno-
precipitates and the input were separated on SDS-PAGE and immunoblots for integrin β4 
and plectin were performed using an antiserum to plectin (#9) and antibodies to integrin 
β4. Plectin and integrin β4 could be detected, in the input and the plectin IP but not the 
control GFP-IP (Figure 14B). This finding indicated that in SCs, plectin is in a complex 
with integrin β4, like in hemidesmosomes of keratinocytes.  
 
Plectins’ interaction with vimentin suggests that in SCs plectin links integrin β4 to the 
vimentin IF network. Likewise, plectin also interlinks the DGC to the vimentin network.  
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Figure 14. Immunoblots demonstrating co-precipitation of integrin β4 and vimentin, 
with plectin. (A) Immunoprecipitation was performed as in Figure 13, but using an 
antiserum to plectin (serum #9) as bait. Samples from the IP were subjected to SDS-
PAGE followed by immunoblotting using antibodies to vimentin. Note that the vimentin 
band (~60 kDa, indicated by an arrowhead), migrates just above the primary antibodies’ 
heavy chain (~55 kDa, indicated by an asterisk). (B) Immunoblot of immuno-
precipitations similar to (A) but using a slightly altered protocol (see method section). 
Antiserum to plectin (#9) was used as bait. The input and the two immuno-precipitates 
were subjected to immunoblotting using antibodies to plectin and integrin β4. Note, co-
precipitation of integrin β4 and plectin. (C) Interaction of a C-terminal plectin fragment 
with a 60 kDa protein expected to be vimentin. A cytoskeleton-associated protein fraction 
from sciatic nerve homogenates was separated on SDS-PAGE and blotted on a membrane 
and probed with his-tagged plectin fragments. A plectin C-terminal fragment was found 
to bind to a 60 kDa protein (arrow). An immunoblot for vimentin confirmed the same 
migration of vimentin. The bracket depicts unspecific bands. 
 
Results                                                                                                                               30                             
3. Changed expression levels of cytoskeletal proteins in  P0-                         
Cre/conditional plectin KO sciatic nerves 
 
To test if the loss of plectin in P0-Cre/cKO mice (a mouse line with a conditional plectin 
specific knock-out in SCs) leads to abnormal expression of its specific binding partners, a 
series of semi-quantitative immunoblottings was performed using sciatic nerve total cell 
lysates. Special emphasis was put on the laminin 211 receptors integrin β4 and members 
of the DGC.  
 
DGC complex:  To evaluate the amounts of expressed proteins, total cell lysates from 
WT and mutant sciatic nerves were prepared. Samples were then separated on SDS-
PAGE and stained with Coomassie. The most prominent bands were densiometrically 
analyzed using the Quantiscan software and samples were normalized to contain equal 
amounts of total proteins. The lysates were then tested for the expression of proteins of 
interest by immunoblotting and the relevant protein bands were semi-quantitatively 
analyzed using the Quantiscan software. The signals derived from P0-Cre/cKO lysates 
were normalized to the signals from the WT lysates, which were set to the arbitrary unit 
1. We observed that full length β-dystroglycan turned out to be slightly reduced in mutant 
sciatic nerves. The decrease of full length β-dystroglycan might be explained by the 
dramatic increase in expression levels of the truncated 30 kDa β-dystroglycan fragment 
(Figure 15). This 30 kDa β-DG fragment is believed to be a result of proteolytic cleavage 
of the extracellular domain β-DG, resulting in a still membrane bound, version of β-DG 
lacking the extracellular domain that is still membrane-bound.   
 
The SC specific dystrophin isoform DP116 was highly upregulated in mutant sciatic 
nerve (Figure 15). This dystrophin isoform with a premature stop codon in its exon 
(Byers et al., 1993), resulting in a 116 kDa large C-terminal isoform of dystrophin, is the 
only expressed isoform of dystrophin in the peripheral nerve. DP116 is able to bind to β-
dystroglycan, but lacks actin-binding (Byers et al., 1993). Although the precise function 
of DP116 in SCs is not known, loss of function in humans was found to cause myelin 
instabilities (Comi et al., 1995). Therefore, its compensatory upregulation, coinciding 
with the loss of plectin, might indicate a role of plectin in stabilizing the DGC. 
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Figure 15. Semiquantitative analysis of expression levels of selected protein 
members of SC laminin 211 receptor complexes. (A) Column diagrams showing 
expression levels of proteins in total cell lysates derived from P0-Cre/cKO sciatic nerves, 
relative to the wild-type samples. Wild-type expression levels were set to an arbitrary unit 
of 1 and are marked by the dashed black line. The numbers of individual experiments 
used for quantification are indicated above the columns. Error bars indicate the standard 
error of the mean. Statistical significance of the observed differences in expression levels 
was analyzed by unpaired two-tailed student t tests. (B) Representative immunoblots of 
the proteins shown in panel (A). 
 
Utrophin, another member of the dystrophin family, showed reduced expression levels in 
total cell lysates derived from P0-Cre/cKO sciatic nerves (Figure 15). Utrophin was 
shown to link the DGC to actin in SCs (Imamura et al., 2000), and to be responsible for 
maintaining the compartmentalization of myelinating SCs into Cajal bands and 
appositions (Court et al., 2009). Expression levels of other protein members of the DGC 
complex, like α-dystrogylcan and δ-sarcoglycan, were not altered (data not shown). 
 
Integrin β4: We also analyzed the expression levels of integrin β4 in sciatic nerve total 
cell lysates from wild-type and P0-Cre/cKO mice. We found that the expression levels of 
integrin β4 in P0-Cre/cKO sciatic nerves were almost two-fold increased relative to 
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nerves from their wild-type littermates. This finding would be consistent with the idea 
that due to compromised stability of the DGC other laminin receptors are upregulated to 
still guarantee sufficient adhesion. 
 
Since vimentin is believed to be the major binding partner of plectin in SCs we also 
analyzed the expression levels of vimentin. In six separate experiments, most of the 
sciatic nerve total cell lysates showed increased expression of vimentin, yet there were 
some samples, where this trend was reversed, overall resulting in an only insignificant 
increase (Figure 15) 
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4. Loss of plectin affects the stability of the SC dystrophin- 
glycoprotein complex 
 
The data obtained from the co-immunoprecipitation experiments demonstrated that in the 
peripheral nerve the SC-specific DGC is linked to the vimentin filament system via 
plectin. Moreover, our semiquantitative immunoblotting analysis revealed increased 
proteolysis of β-dystroglycan, indicating decreased stability of the DGC. To investigate 
this in more detail, subcellular protein fractions of lysates were prepared from wild-type 
and P0-Cre/cKO sciatic nerves. These were then tested for the expression of α-, β-
dystroglycan, and vimentin. 
Reduced β-dystroglycan expression levels in both, the cytoskeletal, 
and membrane-associated protein fractions of P0-Cre/cKO sciatic 
nerves 
 
Wild-type and P0-Cre/cKO sciatic nerves were isolated and used to prepare crude 
homogenates. Subsequently three subcellular fractions were prepared (for details refer to 
the methods section): a cytosolic protein fraction, a membrane-associated protein 
fraction, and a cytoskeleton-associated protein fraction. These fractions were separated 
on an SDS-PAGE and stained with Coomassie. Densitometric analysis was used to 
normalize wild-type and P0-Cre/cKO protein fractions to contain equal amounts of total 
proteins (Figure 16A). Subsequently immunoblots were performed with the normalized 
fractions using antibodies to α-, β-dystroglycan, and vimentin. As shown in Figure 16B, 
we found that vimentin was faithfully located in the cytoskeleton-associated protein 
fraction of wild-type and P0-Cre/cKO nerves.  
 
β-dystroglycan was found mainly in the membrane-associated protein fraction and to a 
lesser extent in the cytoskeletal fraction (Figure 16B). Consistent with the idea that the 
loss of the plectin-mediated linkage of β-dystroglycan to the vimentin cytoskeletal 
network could affect the stability of β-dystroglycan, the β-dystroglycan levels in the 
cyoskeletal fraction of P0-Cre/cKO nerves were found to be severely reduced (Figure 
16B). Additionally, the levels of β-dystroglycan in membrane-associated protein fraction 
were also found to be decreased. This was however contradictory to the observation that 
in P0-Cre/cKO sciatic nerve total cell lysates the overall expression levels of β-
dystroglycan were not reduced (Figure 15A). Similar to β-dystroglycan, the α-
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dystroglycan levels in sciatic nerve total cell lysates were not altered in P0-Cre/cKO 
mice. However, we found the protein levels of α-dystroglycan in the cytoskeleton-
associated fractions of P0-Cre/cKO mice to be greatly, and those in the membrane 
associated fraction moderately reduced. Moreover, we found that concomitant with the 
reduction of α-dystroglycan in cytoskeletal and membrane fractions, α-dystroglycan was 
increased in the cytosolic fraction. Since α-dystroglycan is non-covalently bound to β-
dystroglycan, loss of plectin apparently also compromised α-dystroglycan’s linkage to the 
vimentin cytoskeleton. Given the results obtained with total cell lysates the reduction in 
α-dystroglycan levels in the membrane and cytoskeleton-associated protein fractions, 
cannot be explained by a generally lower protein expression. The relocalization of α-
dystroglycan from the cytoskeleton- and membrane-associated protein fractions to the 
cytosolic fractions could be explained by the increased cleavage of β-dystroglycan in the 
plectin-deficient sciatic nerve (see models in Figure 17) 
 
 
 
Figure 16. Expression levels of DGC proteins in sciatic nerve subcellular fractions. 
Crude homogenates from wild-type and P0-Cre/cKO sciatic nerves were prepared and 
these were used to obtain the following subcellular protein fractions: a cytosolic protein 
fraction (Sn), a membrane-associated protein fraction (MEM) and a cytoskeleton-
associated protein fraction (CSK). These fractions were normalized to contain equal 
amounts of total proteins. (A) Coomassie stained SDS-polyacrylamid gel with 
normalized fractions loaded. (B) Representative immunoblots from four individually 
performed experiments using antibodies to α- and β-dystroglycan and to vimentin on 
normalized subcellular fractions. The numbers underneath the lanes indicate the relative 
expression levels of proteins in mutant fractions after densitometric analysis. 
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Increased proteolytic cleaveage of β-dystroglycan in P0-
Cre/conditional plectin KO sciatic nerve 
 
A matrix-metalloprotease, identified as MMP9 (Michaluk et al., 2007), was shown to 
cleave β-dystroglycan in peripheral nerve, kidney, lung and smooth muscle, but not 
skeletal muscle, cardiac muscle or brain (Yamada et al., 2001). Interestingly, this 
processing was shown to be much stronger in a cardiomyopathic hamster lacking 
sarcoglycan (Matsumura et al., 2003). The main cleavage site is located in the 
extracellular domain of β-dystroglycan, leaving a membrane-bound intracellular 30 kDa 
large fragment and thus shedding the extracellular part from the cell (Bozzi et al., 2009a). 
The extracellular part of β-dystroglycan, and all other bound proteins, like α-
dystroglycan, become released from the cell, thus becoming part of the soluble, cytosolic 
protein fraction (Figure 17). 
 
 
 
Figure 17. Hypothetical models explaining increased solubility of α-DG in P0-
Cre/cKO sciatic nerve. In the wild-type situation, plectin is believed to interlink β-
dystroglycan and vimentin, thus stabilizing the receptor complex through its anchorage 
with the cytoskeleton. In P0-Cre/cKO SCs, increased proteolytic cleavage of β-
dystroglycan trough MMPs in the absence of plectin provides an explanation for the loss 
of α-dystroglycan in the cytoskeletal- and membrane-associated fractions and its 
accumulation in the cytosolic protein fraction. 
 
 To investigate if MMP 2 or MMP 9 expression levels or their activities were upregulated 
and/or more active in P0-Cre/cKO sciatic nerve, homogenates from sciatic nerves from 
wild-type and P0-Cre/cKO mice were prepared and subjected to gelatin zymography.  
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All matrix metalloproteases contain a propeptide, preceding the catalytic domain. The 
propeptide is covering the catalytic domain to keep the protease in a latent, inactive form. 
For activation, the propeptide needs to be cleaved (for review see Kerkelä and Saarialho-
Kere, 2003). Consequently, during separation by SDS-PAGE, the active enzyme would 
migrate further and can be distinguished from the latent form. In a gelatin zymography, 
samples are separated by SDS-PAGE with gelatin being incorporated into the separation 
gel. The gelatinases in the samples, activated by unfolding through SDS in the gel, cleave 
the gelatin which becomes visible as negative stainings after incubation and destaining 
with Coomassie (for details refer to the materials and methods section). Figure 18 shows 
that we were able to detect MMP2 expression in homogenates prepared from wild-type 
and P0-Cre/cKO sciatic nerves, and that no alterations in the expression or activity of 
MMP2 could be observed between wild-type and P0-Cre/cKO samples. The biochemical 
nature of MMP2 was tested by pre-incubating the samples with EDTA and or serine 
protease inhibitors before performing the zymography. EDTA slightly reduced the 
MMP2 signal, whereas the serine protease inhibitors PMSF and AEBSF had no effect, 
indicating that the signal is really stemming from a matrix metalloprotease (Figure 18). 
We were unable to detect a signal for MMP9 activity using zymography. Maybe the 
expression of MMP 9 in sciatic nerve was below the detection limit of our zymography 
protocol. 
 
 
 
Figure 18. Gelatin zymography using 
sciatic nerve homogenates as samples. 
Sciatic nerves from wild-type and P0-
Cre/cKO mice were used to prepare 
homogenates. These samples were then 
subjected to a gelatin zymography. 
Proteases in the samples migrate in the 
SDS acrylamide gel, according to their 
molecular mass and cleave the gelatin, 
which then diffuses out of the gel. This can 
be visualized by staining the gelatin with 
Coomassie and subsequent destaining. 
Individual metalloproteases are identified by their specific molecular masses. Incubating 
the samples with 20 mM EDTA prior to zymography resulted in reduced signal intensity, 
hardening the assumption that the band visible at ~66 kDa is the matrix metalloprotease 
MMP2. No variations in the expression levels of MMP2 could be detected between 
samples from wild-type and P0-Cre/cKO mice. No expression of MMP9 could be 
detected. 
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5. Compartmentalization of differentiated SCs is not altered in 
nerve fibers from P0-Cre/conditional plectin KO mice 
 
The basal lamina, the myelinating SC and the axon were shown to mutually influence 
each other (Chernousov and Carey, 2000). Contact with an axon triggers a SC to 
differentiate and form compact myelin (Wood et al., 1990). SCs on the other hand dictate 
the axonal differentiation into distinct domains (Court et al., 2009). To manage this 
function, the SCs are dependent on stable anchoring and signals from the basal lamina. 
Alterations of receptors in the abaxonal and adaxonal SC membrane have been shown to 
lead to changes in the organization of the myelinating SC, resulting in misorganized 
axons and neuropathies (Roa et al., 1993; Previtali et al., 2003b; Saito et al., 2003; Nodari 
et al., 2008) . To test for possible alterations in the compartmentalization of myelinating 
SCs in sciatic nerves of P0-Cre/cKO mice, immunofluorescence stainings of teased 
sciatic nerve fibers were performed. We analyzed the compartmentalization of the 
myelinating SC into Cajal bands and appositions. The appositions are compartments of 
the SCs where the abaxonal membrane is in close proximity to the compact myelin. 
Appositions are regions where the dystroglycan-drp2-periaxin complex can be found (see 
Figure 7B). DRP2 is localized exclusively in appositions and therefore provides a perfect 
marker for appositions. The intermediate filament protein vimentin was used to label the 
cytoplasmic region of the SCs, namely Cajal bands and their interlinking trabeculae. As 
can be seen in Figure 19A,B, the cytoplasm of SCs of wild-type and P0-Cre/cKO sciatic 
nerves was similarly organized into Cajal bands and appositions. Another important 
structure in myelinating SCs are the Schmidt-Lanterman incisures (SLIs). They can be 
viewed as radial cytoplasmic channels which connect the abaxonal and adaxonal 
cytoplasm. They represent regions where the myelin is not compacted. E-Cadherin was 
used as a marker for the SLIs. No alterations in the frequency or the architecture of SLIs 
in fibers from P0-Cre/cKO mice could be detected (Figure 19C,D). A conditional 
knockout of β-dystroglycan in SCs was recently shown to display problems with the 
formation of nodes of Ranvier (Saito et al., 2003). Hence, nodes and paranodes in teased 
nerve fibers of wild-type and mutant mice were stained with antibodies to ezrin and an 
antiserum to paranodin, respectively. Again no changes in the architecture of the 
paranodes and the nodes could be detected between wild-type and P0-Cre/cKO mice 
(Figure 19G-J). 
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Figure 19. Immunofluorescence stainings of teased nerve fibers. Wild-type and P0-
Cre/cKO nerves were fixed with PFA and individual nerve fibers were teased apart and 
immobilized on object carriers. They were subjected to immunofluorescence microscopy 
to test for alterations in their compartmentalization. Fibers were immunostained using 
antibodies to DRP2 (A,B), vimentin (A,B,E,F), E-cadherin (C,D), integrin β4 (E,F), 
paranodin (G,H) and ezrin (I,J). Note, normal compartmentalization of the SC cytoplasm 
into Cajal bands and trabeculae (A,B) and Schmidt-Lantermann incisures (C,D). Also 
note that contrary to previous reports integrin β4 was found to be concentrated in Cajal 
bands (E,F). SCs also showed no abnormalities in the formation of paranodes (G,H) and 
nodes (I,J) in teased fibers from P0-Cre/cKO mice. 
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Having identified integrin β4 as binding partner of plectin in SCs, we also analyzed its 
localization in the myelinating SC. Although integrin β4 has been described before to be 
evenly distributed in the abaxonal membrane of myelinating SCs we found it to be 
concentrated in Cajal bands (Figure 19E,F). However no changes in the localization of 
integrin β4 were found between wild-type and P0-Cre/cKO SCs. 
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6. Phenotypic analyses of primary wild-type and P0-
Cre/conditional plectin KO SCs 
 
Primary SCs represent SCs in their undifferentiated state. These non-myelinating SCs 
provide a good model for the behavior of SCs in the regenerating nerve when the SCs are 
actively migrating and proliferating. Primary SCs derived from wild-type and P0-
Cre/cKO sciatic nerves were isolated and tested for basic cell parameters, including 
morphology, adhesion, migration, proliferation and their capacity to react to extracellular 
signals. 
P0-Cre/cKO primary SCs display unaltered morphology 
 
To analyze the morphology of wild-type and P0-Cre/cKO primary SCs, they were 
isolated and seeded on cell culture dishes coated with laminin 111. They were fixed by 
treatment with methanol and, after blocking, immunostained with antibodies to actin and 
P75, a SC-specific protein. Ten individual images of randomly chosen fields were 
recorded with a 10 x objective using an LSM 510 microscope (Carl Zeiss). The SCs were 
counted and classified according to the numbers of their extensions. This experiment has 
only be performed once and therefore the results have to be considered as preliminary. 
However, from the 500 SCs counted per genotype it appeared that there were no 
alterations in the numbers of extensions. Most SCs did exhibit a bipolar shape, and about 
10 percent of the SCs counted showed a tripolar shape. SCs posessing only one or more 
than three extensions were rarely observed (Figure 20). 
 
 
 
 
Figure 20. Comparison of wild-type 
and P0-Cre/cKO SC morphology. 
Wild-type and P0-Cre/cKO primary SCs 
were isolated and seeded on laminin 
111- or 211-coated dishes. Three days 
later, the cells were fixed with methanol 
and immunostained using antibodies for 
actin and P75. In this experiment, 500 
cells of each genotype were scored for 
their number of processes. Most cells exhibited a bipolar phenotype. No alterations 
between wild-type and P0-Cre/cKO SCs could be observed. 
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Reduced migratory potential of primary P0-Cre/conditional plectin KO 
SCs on laminin 211 but not on laminin 111 
 
Several different cell types including fibroblasts, T cells and keratinocytes have been 
shown to display altered migratory behavior in the absence of functional plectin 
(Abrahamsberg et al., 2005; Osmanagic-Myers et al., 2006). To assess their migration 
potential, SCs were isolated from wild-type and P0-Cre/cKO sciatic nerves and seeded 
onto laminin 111 or 211. Phase-contrast images were taken every 30 minutes for a total 
of 24 hours from 10 randomly chosen positions. The migration of individual cells was 
analyzed by tracking the position of SC nuclei using the ImageJ software (NIH). On 
laminin 111, three individual experiments were performed, monitoring the migration of a 
total of 90 cells. The results presented in Figure 21 show that the migration of plectin-
negative primary SCs on laminin 111 was not altered. Despite large variations between 
migration velocities of individual cells, the bulk of cells migrated with velocities in the 
range of 0.02-0.05 µm/min. Two individual experiments, monitoring the migration of a 
total of 90 cells were performed with SCs seeded onto laminin 2. The results, albeit being 
preliminary, showed a reduction in the migration velocities of P0-Cre/cKO primary SCs. 
The migration velocities of wild-type SCs on laminin 211 were comparable to that of SCs 
on laminin 111. These results indicate a role for plectin in regulating laminin 211 
dependent cell migration. 
 
 
Figure 21. Analyses of the migratory potential of wild-type and P0-Cre/cKO SCs. 
Wild-type and P0-Cre/cKO primary SCs were seeded onto laminin 111 (A) or laminin 
211 (B) and tested for their migration potential. Phase-contrast images were taken in 30 
minutes intervals for a total timeframe of 24 hours. The manual tracking plugin from the 
ImageJ software (NIH) was used to track nuclei of single, bipolar SCs. Box and whiskers 
indicate the median (middle line in the box) 25th percentile (bottom line of the box), 75th 
percentile (top line of the box) and 2,5th and 97,5th percentiles (whiskers). n=3 for cells 
(total number 90) growing on ln 111, n=2 for cells (total numbers 60) growing on ln 211. 
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Altered adhesion and proliferation of primary P0-Cre/conditional 
plectin KO SCs on laminin 111 and 211 
 
One of the functions of laminin receptors is to mechanically attach the cell to the basal 
lamina. Given that plectin is a cytoskeletal component of the laminin receptor complexes 
found in SCs, an experiment was performed to test for the ability of wild-type and P0-
Cre/cKO primary SCs to attach to laminin 111- or 211-coated surfaces. Equal cell 
numbers of wild-type and mutant primary SCs were seeded on dishes coated with either 
laminin 111 or 211. 24 hours after seeding, phase-contrast images were recorded and the 
cells were counted. Attached cells were also counted after 72 and 96 hours after seeding 
to detect changes in survival and proliferation rates. This experiment has only been 
repeated once and therefore the results have to be considered preliminary. However, the 
results indicated not only differences in the attachment of SCs to laminin 111- and 211-
coated surfaces, but also between the adhesion potentials of wild-type and P0-Cre/cKO 
SCs. Figure 22 shows the percent increase in the number of SCs growing on laminin 211, 
compared to the number of SCs growing on laminin 111. Twenty four hours after 
seeding, 81% more wild-type SCs were counted, attached to the laminin 211 surface 
compared to laminin 111. Intringuingly, P0-Cre/cKO SCs when seeded on laminin 211 
were increased in number by only 16%, compared to laminin 111. This trend also 
persisted 72 and 96 hours after seeding. These data indicated an advantage for SCs to 
attach to laminin 211 compared to laminin 111. However, SCs lacking plectin seemed to 
be unable to benefit from this advantage. These results, albeit preliminary, further stress 
plectin’s role as part of a laminin 211 receptor complex in SCs. 
 
 
Figure 22. Altered adhesion of wild-
type and P0-Cre/cKO SCs. Primary 
wild-type and P0-Cre/cKO SCs were 
seeded onto laminin 111- or 211-coated 
dishes. After 24, 72 and 96 hours, 
phase-contrast images were taken with 
a 10x objective from randomly chosen 
optical fields and attached SCs were 
counted. More than 400 cells of each 
genotype were counted for each 
timepoint in this experiment. 
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Increased extension retraction of primary P0-Cre/conditional plectin 
KO SCs upon treatment with LPA 
 
Lysophosphatidylic acid (LPA) is a small serum phospholipid which is also active in the 
nervous system. Its many biological roles are mediated by G-protein-coupled receptors 
(Noguchi et al., 2009). SCs were shown to express receptors for LPA (Weiner and Chun, 
1999) and LPA-mediated responses include changes in SC morphology (Weiner et al., 
2001; Bouquet et al., 2007), promotion of SC survival and differentiation (Weiner and 
Chun, 1999) and demyelination in ex vivo culture of dorsal root ganglia (Fujita et al., 
2007) as well as in dorsal roots in vivo leading to initiation of neuropathic pain (Inoue et 
al., 2004). To monitor possible alterations of P0-Cre/cKO SCs in response to LPA 
treatment, wild-type and primary P0-Cre/cKO SCs were isolated and grown on laminin 
111-coated dishes. Phase-contrast images were taken and LPA was added to the medium 
in a final concentration of 10 µM. Images were taken in 30 second intervals for a total of 
30 minutes. The ImageJ software (NIH) was used to measure the length of cell-processes 
from single bipolar SCs. Three individual experiments were performed and in each 
experiment 30 cell processes were measured. In P0-Cre/cKO SCs, the processes started to 
retract within 10 minutes after addition of LPA and became reduced to 50% of their 
original length. In contrast, in wild-type SCs no abrupt reduction in cell process length 
could be observed. Thirty minutes after addition of LPA, wild-type SC cell process 
length was still at 60% of T0 (Figure 23). 
 
 
Figure 23. Altered reaction of wild-
type and P0-Cre/cKO SCs to LPA 
treatment. SCs were cultivated for 48 
hours. Lysophosphatidic acid (end-
concentration: 10 µM) was added and 
images were taken each 30 seconds for a 
total timeframe of 30 minutes. Cell 
process lengths of SCs with a bipolar 
shape, not attached to other SCs, were 
measured for each timepoint using the 
ImageJ software (NIH). The graph 
shows the mean results ± SEM, from 3 
individual experiments with 90 SCs per 
genotype analyzed in total.  
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Discussion 
 
In this diploma thesis, I provide evidence for the existence of stable ECM-receptor-
plectin-IF network connections in SCs. With biochemical methods I could show direct 
interaction of plectin with two membrane-bound receptor complexes, integrin α6ß4 and 
the DGC. Making use of a recently established mouse line (P0-Cre/cKO) with a SC-
specific conditional plectin knock-out, the destabilization of these receptor complexes 
upon plectin deficiency could be shown. The finding that a reduced linkage of the DGC 
to the IF network coincided with an increased cleavage of ß-dystroglycan in plectin-
deficient mice was particularly interesting, as this cleavage leads to the loss of the 
extracellular, laminin-binding part of the DGC. This loss of laminin-binding capacity 
could offer an explanation for the phenotypes observed in plectin-deficient primary SCs, 
which included reduced migratory potential, reduced attachment to laminin 211, and 
increased process retraction upon treatment with LPA. Important questions arising from 
these data were if the above phenotypes were caused by changes in receptor stability or 
by other mechanisms such as compromised signaling.  
 
The ECM-plectin-IF axes 
 
In this diploma thesis I could demonstrate interaction of plectin with two laminin 211 
receptors of sciatic nerve, integrin β4 and β-dystroglycan. In keratinocytes, integrin β4 
and plectin isoform 1a constitute (among other proteins) the hemidesmosome, a 
junctional complex that links the keratinocytes cytoskeleton to the basal lamina 
(Rezniczek et al., 1998). No hemidesmosome-like structure can be found in SCs and 
expression of plectin isoform 1a could not be detected. However, integrin β4 was found 
to be expressed in SCs and could be co-precipitated with plectin from sciatic nerve 
homogenates. In keratinocytes, plectin was shown to interact with integrin β4 via 
multiple domains including the ABD, the plakin domain and the C-terminal repeats, with 
the intermediate filament binding domain (IFBD) in particular (Rezniczek et al., 1998). 
Although there was evidence that plectin’s first (isoform-specific) exon influences the 
binding efficiency to integrin β4 (Litjens et al., 2003), theoretically all plectin isoforms, 
including 1 and 1c, should be able to bind to integrin β4. In hemidesmosomes, plectin 
interlinks integrin β4 to the IF network by binding to keratins via its C terminus. In this 
thesis, plectin was shown by Co-IP and blot-overlay assays to bind to vimentin expressed 
Discussion                                                                                                                          45                            
in sciatic nerve. Furthermore plectin, integrin β4, and vimentin were shown by 
immunofluorescence microscopy of teased nerve fibers to be localized in the same 
compartment in myelinating SCs, namely the Cajal bands and interlinking trabeculae. 
These results suggest the existence of an integrin β4-plectin-vimentin IF network axis in 
SCs.  
 
Plectin was shown to bind to β-dystroglycan directly (Rezniczek et al., 2007) and to 
associate indirectly with the DGC, via α-dystrobrevin (Hijikata et al., 2008). In this 
thesis, the binding of plectin to β-dystroglycan in SCs was demonstrated using Co-IP. 
With β-dystroglycan binding sites residing at the N terminus (plakin domain) as well as 
the C terminus, theoretically all plectin isoforms are able to interact with β-dystroglycan. 
Two isoforms, plectin 1 and 1f, were found to be expressed in SCs at low levels, 
consistent with previously reported protein and mRNA levels in brain (Fuchs et al., 
1999). However lower expression levels would not exclude them from playing critical 
roles in the peripheral nerve. When concentrated at specific subcellular locations, the 
local concentration of plectin isoforms 1 or 1f might be higher than that of plectin 1c, 
which probably is the most prominently expressed isoform of plectin in SCs. 
Intringuingly, both isoforms were shown to be associated with the sarcolemma in skeletal 
muscle (Rezniczek et al., 2007; Hijikata et al., 2008). Plectin isoform 1 was shown to 
bind to α-dystrobrevin via the sequence encoded by its exon 1 (Hijikata et al., 2008). α-
dystrobrevin as component of the DGC would thus link plectin to the costamers. The 
authors proposed a model where plectin isoform 1 would help to build a basal lamina-
dystroglycan-dystrobrevin-plectin-actin/IF axis (Hijikata et al., 2008). Plectin isoform 1f 
is even more prominently expressed at the sarcolemma of skeletal muscle (Rezniczek et 
al., 2007). Plectin was shown to directly bind β-dystroglycan via its plakin domain 
(Rezniczek et al., 2007). All plectin isoforms could theoretically bind to β-dystroglycan 
in this manner but only plectin isoforms 1 and 1f were shown to be membrane associated 
by immunfluorescence microscopy (Rezniczek et al., 2007). These findings make plectin 
isoforms 1 and 1f the most likely candidates to mediate interactions with laminin 211 
receptors in SCs.  
 
To assess the functional consequences of plectin’s association with the DGC, subcellular 
protein fractions were prepared from wild-type and P0-Cre/cKO sciatic nerves and tested 
for the expression of DGC constituent proteins. The observed decrease of β-dystroglycan 
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in the cytoskeleton-associated fraction in P0-Cre/cKO could be explained by the loss of 
plectin-mediated linkage to the IF network. The same experiment revealed that the 
expression of α-dystroglycan was reduced in the cytoskeleton and membrane-associated 
protein fraction, but was increased in the cytosolic fraction. This shift in α-dystroglycan’s 
distribution could be the consequence of increased cleavage of β-dystroglycan in P0-
Cre/cKO sciatic nerve, resulting in generation of a 30 kDa β-dystroglycan fragment. 
There is evidence that this fragment is the product of proteolytic cleavage of β-
dystroglycan, mediated by the matrix metalloprotease 9 (MMP9) (Michaluk et al., 2007). 
This phenomenon was termed β-dystroglycan processing. Increased β-dystroglycan 
cleavage is frequently observed in tumor cells (Kerkelä and Saarialho-Kere, 2003; Singh 
et al., 2004), in pathologies like autoimmune neuritis (Zhao et al., 2010) and, intriguingly, 
also whenever an important component of the DGC is missing. In basal keratinocytes β-
dystroglycan processing was shown to be increased when perlecan, a major ligand of α-
dystroglycan was missing. This led to the assumption that a destabilization of the DGC 
makes it more accessible to processing (Herzog et al., 2004). In another report it was 
shown that also the loss of the sarcoglycan complex led to a destabilization of the DGC 
complex, resulting in increased cleavage of β-dystroglycan in skeletal, cardiac, and 
smooth muscle (Matsumura et al., 2003). The authors hypothesized that the sarcoglycan 
complex would mask the cleavage site. In sarcoglycan-deficient mice the site would be 
accessible, leading to increased cleavage. Increased processing of β-dystroglycan in SCs 
was also reported in mdx mice (mice lacking dystrophin) (Hnia et al., 2006). The authors 
could show increased expression of MMP9 in these mice. In this thesis I was able to 
show, using zymographic analyses, that the MMP2 expression level in P0-Cre/cKO 
sciatic nerve was comparable to that of wild-type. However, I was unable to detect 
MMP9, neither in wild-type nor P0-Cre/cKO nor mdx sciatic nerve homogenates. 
Possible reasons could include the insufficient amount of input material or an 
inappropriate protocol. Further efforts are needed to clarify this matter. Consequently, the 
question if the increased cleavage of β-dystroglycan was caused by an increased 
activity/expression of MMP9 or an increased accessibility of the cleavage site can not be 
answered to date. Nevertheless, a hypothetical model of MMP9-mediated processing of 
β-dystroglycan in the wild-type and the P0-Cre/cKO situation in SCs is depicted in 
Figure 13C,D. In this model, the loss of plectin destabilizes the DGC, leading to 
increased MMP9-mediated cleavage of β-dystroglycan. Consequently the extracellular 
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part of β-dystroglycan, and all bound proteins (like α-dystroglycan) are shed from the 
cell.  
Phenotypic consequences of plectin deficiency 
 
To study the phenotypic consequences of plectin deficiency in SCs I isolated wild-type 
and P0-Cre/cKO primary SCs and assessed some of their basic properties such as 
attachment and migration. My results showed a reduction of migration velocity of P0-
Cre/cKO SCs grown on laminin 211. Previous studies had created an ambivalent picture 
regarding the consequences of plectin ablation for cell migration. Plectin-null fibroblasts 
were shown to exhibit reduced motility (Andrä et al., 1998) compared to wild-type cells, 
while in contrast, plectin-null keratinocytes showed increased motility in wound closure 
assays compared to their wild-type counterparts (Osmanagic-Myers et al., 2006). These 
differences in the migratory potential of different cell types could be explained by the fact 
that migration represents a highly complicated and well regulated task for cells. 
Migration is dependent on the combined and precisely orchestrated actions of the actin-
myosin-based cytoskeleton and junctional complexes that attach the cell to its substratum. 
It has been demonstrated that plectin-null fibroblasts show delayed reaction to stimuli of 
the Rho/Rac/Cdc42 pathways, which are known to be major regulators of actin dynamics 
(Andrä et al., 1998). Furthermore plectin might sequester actin or act as a capping protein 
to alter actin dynamics. Additionally, plectin was suggested to act as a scaffold for 
signaling molecules or receptors like RACK1 (Osmanagic-Myers and Wiche, 2004) or 
members of the MAP kinase pathway (Osmanagic-Myers et al., 2006). In this role, 
plectin could control the intracellular localization of these molecules, thus regulating their 
activity.  Furthermore, one could think of a situation where signals transduced from an 
ECM-receptor need linkage to the cytoskeleton to work properly. In fact, this scenario 
has been described in a study of Zhu and Assoian, 1995, where it was shown that 
activation of ERK1/2 and MAP kinase by binding to fibronectin was dependent on an 
intact microfilament system. The fact, that migration was reduced in P0-Cre/cKO SCs 
growing on laminin 211, but not growing on laminin 111 points to a role for a laminin 
211 receptor. The model, that loss of plectin blocks signaling mediated by a laminin 211 
receptor, thereby reducing the migratory potential, is appealing but highly speculative at 
this timepoint. A recent publication where ß-dystroglycan was knocked-down using 
siRNA in myoblasts showed that reduced ß-dystroglycan levels led to reduced migration 
velocity accompanied by increased numbers of fibrillar contacts (Thompson et al., 2010). 
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These data correspond with the observations of reduced migration velocities of plectin-
deficient SCs.  
 
To assess the capacity of plectin-deficient primary SCs to react to extracellular signals, 
they were treated with LPA. My studies indicated that process retraction after the 
addition of LPA was increased in P0-Cre/cKO SCs. Like migration, the event of process 
retraction is highly regulated and influenced by many parameters. In a study highlighting 
the importance of MAP1b for this process, evidence was provided that process retraction 
in SCs after the addition of LPA requires the combined action of actin and tubulin 
rearrangement (Bouquet et al., 2007). Actin remodelling in response to LPA treatment in 
SCs and neurons was shown to be dependent on an increase in myosin activity (Bouquet 
et al., 2007). This is in accordance with reports, demonstrating that LPA treatment 
increases Rho signaling (Amano et al., 1998; Hirose et al., 1998). Since it was shown that 
fibroblasts lacking plectin display delayed reactions to stimuli of the Rho/Rac/Cdc42 
pathway (Andrä et al., 1998) one might assume that the retraction in P0-Cre/cKO SCs 
would be slowed down. However, the delayed reaction to stimuli of the Rho pathway was 
shown in fibroblasts and the situation in SCs might be different. Furthermore, there is 
evidence, that also the microtubules in SCs undergo rearrangement after treatment with 
LPA (Bouquet et al., 2007). Plectin’s mechanical stabilizing might hinder the collapse of 
SC extensions. Of course, attachment to the substratum is another parameter that has to 
be considered in the event of process retraction. The experiments with LPA were 
performed with SCs grown on laminin 111. A preliminary experiment suggested that 
there were no variations in the attachment of wild-type and P0-Cre/cKO SCs on laminin 
111 (data not shown). However, altered signaling via laminin 111 receptors can not be 
ruled out. It will need further experiments to find out if the reduced retraction is due to 
changes in signaling, altered mechanical features, or a combination of the two. 
No role for plectin in compartmenatlization of myelinating SCs? 
 
Immunofluorescence microscopy of teased nerve fibers from wild-type and P0-Cre/cKO 
sciatic nerves indicated that plectin is dispensable for the correct compartmentalization of 
myelinating SCs and differentiation of axonal domains. Using antibodies to proteins that 
are specifically located in certain subcellular domains of myelinating SCs, these domains 
were visualized to monitor possible alterations. No variations of P0-Cre/cKO nerve fibers 
could be observed regarding the organization of nodes, paranodes and Schmid-
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Lantermann incisures. Furthermore, mutant nerve fibers did not display any alterations in 
the organization of Cajal bands and membrane-myelin appositions. These observations 
suggest that SCs do neither need plectin to receive and transduce myelination and 
differentiation signals, nor to orchestrate the necessary intracellular changes.  
 
Most undifferentiated primary SCs exhibit a bipolar phenotype with a central cell body 
and two long, slim extensions. Primary SCs isolated from P0-Cre/cKO mice showed no 
altered morphology, with respect to their extension numbers. However further 
morphological analyses of P0-Cre/cKO SCs have to be performed, including cell size and 
process cytoarchitecture. Compensatory mechanisms could explain the lack of alterations 
in SC compartmentalization, SC morphology, and axonal organization of P0-Cre/cKO 
mice. To adress this question, I analyzed the expression levels of the key protein 
constituents forming the ECM-IF network axes in SCs. A similar analysis in wild-type 
and P0-Cre/cKO sciatic nerve revealed a statistical significant increase of DP116 and 
integrin β4 as well as a decrease in the expression of utrophin in plectin-null nerves. 
DP116 is a SC-specific isoform of dystrophin (Byers et al., 1993), which possesses a 
premature stop codon, resulting in the expression of a 116 kDa large C-terminal isoform 
of dystrophin. This isoform is able to bind to β-dystroglycan, but lacks an actin-binding 
domain, and hence is unable to link β-dystroglycan to actin, such as dystrophin does in 
skeletal muscle. Although the precise function of DP116 in SCs is not known, loss of 
function in humans was found to cause myelin instabilities (Comi et al., 1995). 
Therefore, its upregulation appears to compensate for the destabilization of the α/β-
dystroglycan-cytoskeleton axis in the absence of plectin. 
 
The upregulation of integrin β4 in P0-Cre/cKO sciatic nerve is likely a result of the SCs’ 
efforts to compensate for the loss of plectin’s mechanical linkage. Thus, the decrease in 
the expression levels of utrophin in P0-Cre/cKO sciatic nerve compared to wild-type 
came as a surprise, as one might have expected that this protein, too, would show 
upregulation. In fact in skeletal muscle utrophin is upregulated in plectin-null mice. It 
will be highly interesting to investigate these differences in regulation in various cell 
types. 
 
This diploma thesis delivered insights into the roles, plectin plays in SCs of the peripheral 
nervous system. The acquired data suggests a stabilizing role for plectin in interaction 
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with the DGC and the integrin α6ß4 laminin receptor complex. Absence of plectin was 
shown to lead to compensatory upregulation of key constituents of these complexes as 
well as a destabilization of the DGC, ultimately resulting in the loss of the laminin 
binding part of the receptor complex – α-dystroglycan. It will be interesting to adress the 
question how the increased proteolytic cleavage of ß-dystroglycan in plectin deficient 
sciatic nerve is mediated. One could assume that either the destabilization of the complex 
leads to increased accessibility of the cleavage site, or an increased expression or activity 
of the metalloproteinase cleaving ß-dystroglycan leads to the observed changes. Further it 
will be of great interest to investigate what caused the observed reduction in motility and 
the increased process retraction upon stimulation with LPA of primary plectin-null SCs. 
Assessing the capability of plectin-null SCs to react to stimuli of the Rho/Rac/Cdc42 
pathways might help solve this puzzle. Generally, we are far from a comprehensive 
understanding of plectins functions in Schwann cells but this thesis helped guide the 
directions for further research. 
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Materials and Methods: 
 
Preparation of subcellular fractions from mouse and rat sciatic nerve 
 
Mice were anesthetized with 200 μl of isofluoran (Abbott) and subsequently killed by 
cervical dislocation. Rats were euthanized with CO2. The sciatic nerves were removed, 
snap frozen in liquid nitrogen and pulverized thoroughly using a mortar and pistil under 
permanent coverage with LN2. 75 μl of phosphate extraction buffer were added per 1 cm, 
of original nerve length and the pulverized nerves were homogenized with 20 strokes 
using a dounce homogenizer. The resulting crude homogenate was transferred to 
Eppendorf tubes and centrifuged at 4° C for 10 minutes at 82 x g to sediment cell debris. 
The resulting supernatant was transferred to a fresh Eppendorf tube and the pellet 
discarded. 50 μl of the supernatant were mixed with 50 μl 6 x SDS sample buffer, 
incubated for 5 minutes at 95° C and stored at -20° C as crude homogenate (CH).  
 
The rest of the supernatant was centrifuged at 53,000 rpm in a Beckman TLX 
Ultracentrifuge (TLA-120.2) for 1 hour at 4° C to pellet crude vesicles. The supernatant 
after ultra-centrifugation was carefully taken off using a needle attached to a small 
syringe and mixed with an equal volume of 6 x SDS sample buffer and treated as 
described above. This fraction was supposed to contain the cytosolic proteins and it was 
marked as cytosolic fraction (CS). 
 
The pellet of the ultra centrifugation was rinsed with 200 μl of Phosphate Buffer and re-
homogenized in 1/8 volume of phosphate detergent extraction buffer (of that of 
phosphate buffer used in the first homogenization step) with a yellow pipette tip by 
pipetting up and down 50 times. The resulting suspension was incubated for 1 h at 4° C 
on a rocking platform to extract membrane proteins. The suspension was then centrifuged 
at 20,000 rpm in a Beckman TLX Ultracentrifuge (TLA-45) for 10 min at 4° C. The 
supernatant containing membrane proteins was carefully removed with a needle attached 
to a syringe and transferred to a fresh Eppendorf tube. The supernatant was mixed with 
an equal volume of 6 x SDS sample buffer and trated as described above. This fraction 
was marked as crude membrane extract, ME. 
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The pellet was rinsed carefully with 200 μl phosphate buffer and rehomogenized in 1/8 
volume of 8 M Urea (of that of phosphate buffer used in the first homogenization step). 
The resulting suspension was incubated on a rocking platform at RT for 30 min. 50 μl of 
this suspension was mixed with an equal volume of 6 x SDS sample buffer, treated as 
described above and marked as cytoskeletal fraction (CSK). 
 
 
Phosphate Extraction Buffer: 
- 20 mM  Na-Pyrophosphate 
- 20 mM  Na-Phosphate 
- 1 mM  MgCl2 
- 0.303 M  sucrose 
- 2 mM  PMSF 
- pH   7.4 
- 1 x Protease Inhibitor Cocktail (Roche) 
 
Phosphate Detergent Extraction Buffer: 
- 20 mM Na-Pyrophosphate 
- 20 mM  Na-Phosphate 
- 1 mM  MgCl2 
- 0.303 M  sucrose 
- 1 % (v/v)  Triton X-100 
- 0.1 % (v/v)  SDS 
- 2 mM  PMSF 
- pH   7.4 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
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Figure 24. schematic presentation of the steps involved in the membrane 
fractionation 
 
 
Co-Immunoprecipitation of β-dystroglycan-binding proteins from rat 
sciatic nerve 
 
Only cut-off pipette tips were used during the co-IPs in order to not disrupt fragile protein 
complexes by shear forces. If not otherwise stated, all steps were carried out on at 4° C. 
 
One adult rat was euthanized with CO2. The sciatic nerves were removed, snap frozen in 
liquid nitrogen and pulverized thoroughly under LN2 coverage using a mortar and pistil. 
The grinded nerve powder was transferred into a 2ml glass-in-glass dounce homogenizer 
and homogenized in 500 μl Hepes-Extraction Buffer with 30 strokes. The suspension was 
transferred into Eppendorf tubes, incubated at RT for 10 min and subsequently 
centrifuged at 4° C for 10 minutes at 1,306 x g to sediment cell debris. The supernatant 
was transferred to a new Eppendorf tube and the pellet was discarded. A 50 μl aliquot 
was removed, mixed with 50 μl of 6 x SDS sample buffer, incubated for 5 minutes at 95° 
C, marked as crude homogenate and stored at -20° C. To the rest of the crude 
homogenate, 100 μl Protein G-sepharose were added and incubated on a rotator for 3 
hours at 4° C to pre-clear the homogenate of proteins that bind unspecific to the beads. 
The sepharose beads were pelleted by centrifugation at 2,040 x g for 5 minutes at 4° C. 
The supernatant was transferred to a fresh 2 ml Eppendorf tube and split into two 
aliquots. 
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To the first aliquot a mix of the anti-β-dystroglycan antisera was added (sera #1709 and 
#1710 kindly provided by S. Winder, diluted 1:20 in PBS). To the second aliquot 10 µg 
anti-EGFP-antibodies (mAb; mouse anti GFP, Roche diagnostics), serving as a control 
were added. The mixtures were incubated over night on a rotator at 4° C. 
 
The next day, 50 μl protein G-sepharose were added and incubated for 6 h at 4° C on a 
rotator. The sepharose beads were pelleted by centrifugation at 326 x g for 3 minutes. 
The supernatant was removed with a needle/syringe, shock frozen in liquid nitrogen and 
stored at -80° C. The sepharose-beads were washed 3 times by addition of 500 μl hepes-
extraction buffer, resuspending the beads by turning the Eppendorf tube bottom up and 
centrifugation at 326 x g for 2 minutes at room temperature. Each time the supernatant 
was removed with a needle/syringe and discarded. Ultimately 50 μl 6 x SDS buffer were 
added to the pelleted sepharose beads, briefly vortexed and boiled at 95° C for 5 minutes. 
After 5 min of centrifugation at 326 x g at RT the supernatant was carefully removed 
with a needle attached to a syringe and stored as immunprecipitate at -80° C. 
 
Hepes extraction buffer: 
- 50 mM Hepes/HCl 
- 0.5 mM  EGTA 
- 5 mM  MgCl2 
- 1% (v/v)  Triton X-100 
- 0.5 mg/ml  DNAse I 
- 0.2 mg/ml  RNAse A 
- 2mM  PMSF 
- pH 7.4 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
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Co-immunoprecipitation of plectin-binding proteins from mouse 
sciatic nerve 
 
Only cut-off pipette tips were used during the co-IPs in order to not disrupt fragile protein 
complexes by shear forces. If not otherwise stated, all steps were carried out on ice. 
 
Adult wild-type mice were anesthetized with 150 μl of isofluran (Abbott) and killed by 
cervical dislocation. The sciatic nerves were removed, immediately transferred into a 2 
ml glass-in-glass dounce homogenizer and homogenized in 70 μl of phosphate-triton 
buffer per cm nerve with 20 strokes. The resulting suspension was transferred into 
Eppendorf tubes and centrifuged at 4° C for 10 minutes at 1,306 x g to sediment cell 
debris. The supernatant was removed and filled up to 1,900 μl with phosphate-triton 
buffer. 100 μl of phosphate-SDS buffer were added to the remaining pellet, followed by 
pipetting to solubilize the otherwise insoluble cytoskeletal proteins. The resuspended 
pellet was incubated for 10 minutes at room temperature and centrifuged at room 
temperature for 10 minutes at 1,306 x g to sediment the still insoluble proteins. The 100 
μl of supernatant were removed and portion-wise added to the 1,900 μl of the initial 
supernatant. This solution was then carefully mixed by pipetting. A 50 μl aliquot was 
removed, mixed with 50 μl of 6 x SDS-sample buffer, incubated for 5 minutes at 95° C, 
marked as crude homogenate and stored at - 20° C. To the rest of the crude homogenate, 
100 μl  protein G-sepharose were added and incubated on a rotator for 3 hours at 4° C for 
the purpose of pre-clearing the crude homogenate. The sepharose beads were pelleted by 
centrifugation at 735 x g for 5 minutes at 4° C. The supernatant was transferred to a fresh 
2 ml Eppendorf tube and split into 2 aliquots.  
 
To the first aliquot anti plectin antibodies were added (a mix of 150μl 10F6 and 4μl #46). 
To the second aliquot anti-EGFP antibodies were added to serve as a negative sample (a 
mix of 5 μl of rabbit-anti-EGFP antibodies and 5 μl of mouse-anti-EGFP antibodies + 
140 μl PBS). The mixtures were incubated on a rotator over night at 4° C. 
 
The next day, 50 μl protein G-sepharose were added and incubated for 6 h at 4° C on a 
rotator. The sepharose-beads were pelleted by centrifugation at 326 x g for 2 minutes. 
The supernatant was removed with a needle/syringe and shock frozen in liquid nitrogen 
and stored at - 80° C. The sepharose-beads were washed 3 times by adding 500 μl 
washing-PBS, resuspending the beads by turning the Eppi tube bottom up and 
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centrifugation at 326 x g for 2 minutes at room temperature. Each time the supernatant 
was removed with a needle attached to a syringe and discarded. 50 μl 6 x SDS buffer 
were added to the pelleted sepharose beads, briefly vortexed and boiled at 95° C for 5 
minutes. After 5 min of centrifugation at 326 x g at RT the supernatant was carefully 
removed with a needle/syringe and stored as immunprecipitate at - 80° C. 
 
Phosphate-triton extraction buffer: 
- 20 mM  Na2P2O7 
- 20 mM  Na-P04 
- 0.5 mM  EDTA 
- 1 mM  MgCl2 
- 0.303 M  Sucrose 
- 1 % (v/v)  Triton X-100 
- 2 mM  PMSF 
- pH   7.4 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
 
Phosphate-SDS extraction buffer: 
- 20 mM  Na2P2O7 
- 20 mM  Na-P04 
- 0.5 mM  EDTA 
- 1 mM  MgCl2 
- 0.303 M Sucrose 
- 0.2 %  BSA 
- 1 % (v/v)  Triton X-100 
- 2 %   SDS 
- 2 mM  PMSF 
- pH   7.5 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
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washing-PBS: 
- 1 x PBS 
- 0.5 % (v/v) Triton X-100 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
 
Preparation of mouse sciatic nerve total cell lysates 
 
Mice were anesthetized with 150 µl isofluran (Abbott) and killed by cervical dislocation. 
The sciatic nerves were removed, shock frozen in liquid nitrogen and subsequently 
pulverized under permanent LN2-cover using a mortar and pilsit. The pulverized nerves 
were further homogenized in a 2 ml glass-in-glass dounce homogenizer using 100 µl 
detergent extraction buffer per 1 cm nerve. 
 
The resulting suspension was transferred to Eppendorf tubes and centrifuged at 4° C for 5 
minutes at 2,040 x g to remove cell debris. The supernatant was transferred to a fresh 
tube and mixed with an equal volume of 5 x SDS - sample buffer. The mixture was 
incubated for 5 minutes at 95° C and centrifuged for 10 minutes at 13,793 x g. The 
supernatant, which was termed sciatic nerve total cell lysate, was transferred to a new 
tube and stored at - 80° C. 
 
Detergent Extraction buffer: 
- 20 mM  Tris/HCl  
- 150 mM  NaCl 
- 1 mM  EDTA 
- 1 % (v/v)  Triton X-100 
- 0.5 % (v/v)  NP-40 
- 1 mM PMSF 
- pH   7.5 
- 1 x Protease Inhibitor Cocktail (Roche) 
- 1 x Phosphatase Inhibitor Cocktail 1 (Sigma) 
- 1 x Phosphatase Inhibitor Cocktail 2 (Sigma) 
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Preparation and immunostaining of teased nerve fibers from sciatic 
nerves 
 
Mice were anesthetized with 150 µl isofluran (Abbott) and killed by cervical dislocation. 
The sciatic nerves were removed and subsequently fixed for 20 minutes in 4 or 2 % PFA 
at RT. The fixed nerves were washed three times with PBS and mounted on an object 
slide. The individual nerve fibers were teased aparat using micro-forceps under a 
stereomicroscope. The slides were stored at -80° C. 
 
All subsequent immunostaining steps were carried out at room temperature. 
For immunostaining, the teased nerve fibers were thawed at room temperature and 
allowed to dry for 15 minutes. After encircling the fibers with a hydrophobic marker they 
were permabilized with 0.1 % Triton X-100 in PBS for 30 minutes. The primary 
antibodies were diluted in PBS and incubated on the slides for 1 h. The slides were then 
washed with PBS and incubated with 0.1 % Triton X-100 in PBS for 5 minutes. The 
secondary antibody coupled to a fluorophor was diluted in PBS and incubated with the 
teased fibers for 1 h. The slides were washed with PBS and incubated with 0.1 % Triton 
X-100 as described above and subsequently incubated with Hoechst dye for 5 minutes 
(Sigma, diluted 1:3,000). The slides were washed one last time with PBS and incubated 
with 0.1 % Triton X-100 for 5 minutes. The slides were washed shortly in ddH2O and 
allowed to dry completely. Finally the slides were mounted with mowiol and air-dried for 
at least 24 hours. Storage was performed at 4° C. 
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Expression of recombinant proteins in E. Coli 
 
Preparation of bacterial glycerol stocks: 
E. Coli (strain BL21, DE3), carrying plasmids expressing recombinant HIS-fusion 
proteins were plated on agar plates containing 100 µg/ml ampicilin and grown overnight 
at 37° C. After colonies were then used to inoculate 100 ml TB medium containing 1 % 
glucose and 100 µg/ml ampicilin. The cultures were incubated over night at 37° C. The 
bacteria were harvested by centrifugation at 3,000 x g for 10 minutes at 4° C and 
subsequently resuspended in sterile TB medium supplemented with 10 % glycerol and 
200 µg/ml ampicilin. The bacteria were aliquoted into 200 µl aliquots, frozen in liquid 
nitrogen and stored at -80° C. 
 
Expression and purification of recombinant proteins in E. coli: 
Bacterial stocks were used to inoculate 200 ml TB medium supplemented with 1 % 
glucose and 100 µg/ml ampicilin. The cultures were incubated at 37° C until an OD600 of 
0,6 was reached. Expression was started by addition of 1 mM IPTG and the bacteria were 
incubated for 4 h at 30° C. The cells were harvested by centrifugation at 10,000 x g for 15 
min at 4° C. The supernatant was discarded and the pellet resuspended in 10 ml buffer A 
and frozen at - 20° C o/n. 
 
Next day the bacteria were thawn on ice and subsequently incubated with lysozyme ( 200 
µg/ml) for 15 minutes at 30° C. The suspension was transferred to SS 34 rotor tubes 
(Sorvall) and sonicated on ice for 10 cycles, 30 sec continuous pulse with 90 % power 
(Bandolin Sonopuls HD70) and cooling with liquid nitrogen in between the cycles. Cell 
debris was pelleted by centrifugation at 10,000 x g for 15 min at 4° C. The supernatant 
was subsequently subjected to affinity purification. 
 
The supernatant was filtered through a 40 µm filter. Purification was performed using a 
fast protein liquid chromatography system (Amersham Biosciences ÄKTA FPLC). 
HIS tagged proteins were purified using a 5 ml HIS tag chelating column (Amersham 
Biosciences). The columns were equilibrated with 5 column volumes (cv) buffer A. The 
filtered protein lysate was applied to the column, which was subsequently washed with 4 
cv buffer A containing 25 mM imidazol. The proteins were eluted with 4 cv buffer B. 
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The collected fractions were analyzed by separation on SDS polyacrylamid gels and 
staining with Coomassie. 
 
Buffer A: 
- 50 mM  Tris/HCl pH 9,0 
- 0,5 M Triton X-100 
- 0,1 mM PMSF 
 
Buffer B: 
- 50 mM  Tris/HCl pH 9,0 
- 0,5 M Triton X-100 
- 500 mM Imidazol 
 
all buffers were filtered through a 22 µm filter and degassed for 2 h. 
 
Dialysis: 
The protein lysates to be dialyzed were pipetted into tubes discriminating particles below 
12 kDa. The tubes were incubated o/n at 4° C in the desired destination buffer (1000 x 
the volume of the sample). 
 
 
Measurements of protein concentrations 
 
Protein concentrations were determined using the BCA Protein Assay Kit (Pierce). 
Alternatively absorption at λ280 nm was measured using the Nanodrop 2000c according 
to the instructions of the manufacturer (Thermo Scientific).  
To normalize total cell lysates derived from wild-type and P0-Cre/cKO sciatic nerve to 
equal protein content, the lysates were separated on SDS polyacrylamid gels and stained 
with Coomassie. The gels were scanned (HP ScanJet 8250C, 300 dpi, 8 bit) and the pixel 
intensities of the most prominent bands were analyzed by densitometry using Quantiscan 
software (Biosoft). Thus the lysates could be normalized to each other. 
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SDS-Polyacrylamid gels / Gel electrophoresis 
 
The SDS-polyacrylamid gels were casted containing the desired acrylamid concentration 
according to table 1. 
Separation gels were overlaid with isopropanol during polymerization. The gel was given 
approximately 20 minutes to polymerize, the isopropanol was removed, the stacking gel 
was added and the comb (10 or 15 slots) was installed. After another 20 minutes  
SDS-polyacrylamid gel electrophoresis was performed using the BioRAD Protean Mini 
II apparatures. 
 
 
      6% 8% 10% 12% 15% stacking gel 4% 
ddH2O   2,6 ml 2,3 ml 1,9 ml 1,6 ml 1,1 ml 0,68 ml 
30 % acrylamide   1,0 ml 1,3 ml 1,7 ml 2,0 ml 2,5 ml 170 µl 
1,5 M Tris/HCl (pH 8,8) 1,3 ml 1,3 ml 1,3 ml 1,3 ml 1,3 ml 130 µl 
10 % SDS  50 µl 50 µl 50 µl 50 µl 50 µl 10 µl 
10 % ammonium persulfate 50 µl 50 µl 50 µl 50 µl 50 µl 10 µl 
TEMED     10 µl 8 µl 6 µl 6 µl 4 µl 2 µl 
Table 1. Solutions for preparing gels for SDS-PAGE. Quantities for 5 ml separation 
and 1 ml stacking gel respectively 
 
 
In cases were samples had not yet been mixed with SDS-sample buffer, they were mixed 
1:1 with 5 x SDS sample buffer and incubated at 95° C for 5 minutes. Samples already 
pre-mixed with SDS-sample buffer were incubated at 95° C for 3 minutes. Immediately 
after heating, the samples were pipetted into the slots of the SDS polyacrylamid gels. The 
gels were covered with electrophoresis buffer and run with the current limited to 20 mA 
for about 2 h at RT.  
 
 
Electrophoresis buffer: 
25 mM Tris 
250 mM Glycine 
0.1 %  SDS 
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Coomassie staining 
 
The polyacrylamid gels were incubated in Coomassie staining solution for 30 minutes at 
RT. They were subsequently destained in destaining solution until the desired contrast 
was achieved. 
 
Coomassie staining solution: 
- 0.5 g  Coomassie blue R250 
- 400 ml methanol 
- 70 ml acetic acid 
ddH2O ad 1l. 
 
Coomassie destaining solution: 
- 10 % (v/v) acetic acid 
- 30 % (v/v) methanol 
- 60 % (v/v) ddH2O 
 
Gelatin Zymography 
 
A 12 % SDS-Polyacrylamid gel was casted as described above, except that gelatin 
(1mg/ml) was added to the separation gel. Mouse sciatic nerve extracts were prepared as 
follows:  
 
Mice were anesthetized with 150 µl isofluran (Abbott) and killed by cervical dislocation. 
The sciatic nerves were removed, snap frozen in liquid nitrogen and subsequently 
pulverized using a mortar and a pistil. The pulverized nerves were further homogenized 
in a 2 ml glass-in-glass dounce homogenizer with 100 µl phosphate extraction buffer per 
1 cm nerve. 
 
The suspension was transferred to Eppendorf tubes and centrifuged at 4° C for 5 minutes 
at 209 x g to remove cell debris. The resulting supernatant was transferred to a fresh tube 
and mixed with an equal volume of 1 x non-reducing SDS - sample buffer. 
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The sciatic nerve-extracts were loaded into the gel and electrophoresis was performed as 
described in the SDS-PAGE section. All incubation steps were carried out on a shaker. 
After protein separation the gel was placed in 2.5 % Triton X-100 in PBS for 1 h at RT to 
wash away the SDS. The gel was then washed twice with substrate buffer and incubated 
in substrate buffer over night at 37° C. Next day the gel was stained for 30 min with 
Coomassie solution and destained by boiling in ddH2O using a microwave oven, until 
optimal contrast was achieved. 
 
Phosphate extraction buffer: 
20 mM NaH2P04 
20 mM Na2HP04 
1 mM  MgCl2 
0,303 M Sucrose 
pH 7,4 
 
5 x non-reducing sample buffer: 
400 mM Tris/HCl 
50 % (v/v) Glycerol 
0.1 % (w/v) Bromphenol blue 
2.5 % (w/v) SDS 
pH 6.8 
 
Substrate buffer: 
50 mM Tris/HCl 
5 mM   CaCl2 
0,02 % (w/v) NaN3 
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Electrotransfer of proteins onto nitrocellular membranes 
 
The blot-sandwich for electric transfer was prepared as depicted in Figure 25: 
 
Figure 25. Immunoblot sandwich assembly 
 
All components were soaked in transfer buffer prior to the sandwich assembly. The 
sponges were additionally rinsed with ddH2O before being soaked in transfer buffer to 
remove remaining salts. Electrotransfer was performed in a wet-blotting tank filled with 
transfer buffer at 4° C o/n at 25 V. 
 
The successful protein transfer was verified by staining with 1 x Ponceau solution for 3 
minutes and subsequent counterstaining with ddH2O. If necessary molecular weight 
standard bands were marked and the membrane was cropped. The membrane was then 
destained with PBS-T. 
 
Transfer buffer: 
25 mM Tris 
250 mM Glycine 
 
10 x Ponceau Solution: 
2 % (w/v) Ponceau S 
30 % (v/v) trichloracetic acid 
30 % (v/v) sulfonsalicylic acid 
40 % (v/v) ddH2O 
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Immunoblotting 
 
All steps were carried out on a shaker. 
 
To block unspecific binding sites on the nitrocellulose membrane, it was incubated in 
either 5 % skimmed milk in PBS - T or 5 % BSA/PBS-T for one hour at RT. The primary 
antibodies directed against the proteins of interest were diluted in 5 % BSA/PBS-T – 0.02 
% NaN3 was added as preservative. The membrane was incubated overnight at 4° C with 
the primary antibodies. On the next day, the membrane was washed 3 x 10 min with 
PBS-T and incubated with the secondary antibody (diluted in PBS-T) for one hour at RT. 
The secondary antibodies were coupled to either HRP0 (horseradish peroxidase) or AP 
(alkaline phosphatase) to allow for visual/chemi-luminescent detection. The membrane 
was washed 3 times 10 minutes in PBS-T before progressing to detection.  
 
Chemiluminescent detection of HRP0-coupled antibodies was performed using the 
SuperSignal West Pico Chemiluminescence substrate (Thermo Scientific) and X-Ray 
films. 
 
For detection of AP-coupled antibodies the membrane was washed once with AP buffer 
and subsequently incubated in AP substrate until optimal intensities of stained bands had 
been achieved. The staining was stopped with PBS.  
 
AP buffer: 
100 mM Tris pH 9.5 
100 mM NaCl 
5 mM  MgCl2 
 
AP substrate: 
66 µl   BCIP stock solution 
66 µl  NBT stock solution 
in 10 ml AP buffer 
 
 
BCIP stock solution: 
50 mg/ml BCIP in 100 % (v/v) DMF 
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NBT stock solution: 
50 mg/ml NBT in 70 % (v/v) DMF 
 
Protein overlay assay 
 
Subcellular fractions prepared from sciatic nerves (membranous/cytoskeletal) were 
separated by SDS-Page as described above. The proteins were transferred onto a 
nitrocellulose membrane by electrotransfer as described above.  
 
All incubation steps were carried out on a shaker. 
 
On the next day the membranes were blocked with 5 % skimmed milk in PBS-T for 3 h. 
The membranes were then incubated with recombinant his-tagged plectin fragments (10 
µg/ml diluted in overlay buffer) over night at 4° C. On the next day the membrane was 
washed 3 x 10 min with PBS-T and subsequently incubated with monoclonal mouse anti-
penta-His antibodies for one hour at RT. The membrane was then washed 3 x 10 min 
with PBS-T and subsequently incubated with goat anti-mouse antibodies coupled to 
HRP0 for one hour at RT. Finally, the membrane was washed 3 x 10 min with PBS-T and 
subjected to chemiluminescent detection as described above. 
 
Cell culture: 
 
All cell cultur techniques were carried out under aseptic conditions in a laminar flow 
hood. Unless otherwise stated all media and solutions used, were pre-heated to 37° C in a 
waterbath. 
 
 .Thawing of frozen cells 
 
Cells stored in liquid nitrogen were rapidly thawed in a water bath at 37° C. The thawed 
cell suspension was immediately pipetted into 10 ml medium and this mixture was 
centrifuged for 3 minutes at 184 x g. The supernatant was discarded and the pellet was 
resuspended in 5 ml of appropriate medium. The suspension was pipetted into a 10 cm 
dish already containing 5 ml medium. The dish was incubated at 37° C, 5 % CO2. 
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.Passaging of cells 
 
The medium was aspirated and the dish was washed with PBS. The cells were incubated 
with trypsin-EDTA until they detached from the dish. The reaction was stopped by 
addition of medium containing serum. The cells were resuspended using a 5 ml pipette 
and transferred to a centrifuge tube. The cell suspension was centrifuged for 3 minutes at 
1.000 rpm. The supernatant was discarded and the pellet was resuspended in appropriate 
medium. Aliquots of the cells were pipetted on new dishes and incubated at 37°C, 5 % 
CO2.  
 
.Freezing of cells 
 
The pellet containing trypsinized cells was resuspended in 500 µl medium B. 500 µl 
medium A were added dropwise and the mixture was transferred to a cryotube that was 
placed in a specialized freezing device (Nalgene, “Mr. Frosty”) filled with isopropanol to 
guarantee slow freezing in a -80° C freezer overnight. On the next day the cells were 
transferred to storage in liquid nitrogen. 
 
medium A: 
20 %  DMSO 
80 %  medium 
4° C 
 
medium B: 
40 %  medium 
60 %  FCS 
37° C 
 
 
Isolation of primary SCs from adult mice 
 
The protocol used was modified from Manent et al. 2002, Mauritz et al. 2004, Niapour et 
al. 2010. 
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Mice were anesthetized with 150 µl isofluran (Abbott) and killed by cervical dislocation. 
The sciatic nerves were removed and immediately put in 4° C cold DMEM-F12 
containing penicillin and streptomycin. The dishes were transferred to a sterile laminar 
flow hood and the nerves were rinsed 3 times with sterile DMEM-F12. Then the nerves 
were placed in a plastic cell culture dish filled with degeneration medium and incubated 
for 10 days at 37° C, 5 % CO2. The degeneration medium was changed twice a week. For 
dissociation, the nerves were rinsed three times in PBS -/- and placed in a 75 cm2 flask 
containing 10 ml dissociation medium. The nerves were incubated for 6 h at 37° C, 5 % 
CO2 with regular agitation. The dissociation was stopped by addition of 20 ml DMEM + 
10 % FCS and the cells were dissociated by pipetting up and down with a fire polished 5 
ml pipet. The suspension was transferred to a falcon tube and centrifuged for 5 min at 
300 x g. The supernatant was aspirated and the pellet resuspended in primary plating 
medium. The SCs were counted in a counting chamber and seeded at the appropriate 
density (usually 1 x 106 cells per 35 mm dish) on laminin 111 coated dishes/coverslips. 
After 24 h the primary plating medium was removed and replaced with growth medium. 
The growth medium was changed twice a week.  
 
Degeneration medium: 
DMEM supplemented with 
10 % (v/v) FCS 
50 µg/ml Gentamycin 
2.5 µg/ml Fungizone 
2 µM  Forskolin 
10 ng/ml Heregulin-β1 (HRG) 
 
Dissociation medium: 
Leibovitz Medium L-15 supplemented with 
130 U/ml Collagenase Typ I 
1.25 U/ml Dispase II 
50 µg/ml Gentamycin 
2.5 µg/ml Fungizone 
Penicillin/Streptomycin. 
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Primary plating medium: 
DMEM supplemented with  
10 % (v/v) FCS 
50 µg/ml Gentamycin 
2.5 µg/ml Fungizone 
2 µM  Forskolin 
1 % (w/v) BSA 
 
Growth medium: 
Melanocyte growth medium supplemented with: 
50 µg/ml Gentamycin 
2,5 µg/ml Fungizone 
2 µM  Forskolin 
5 µg/ml bovine pituitary extract 
10 ng/ml FGF-2 (basic fibroblast factor) 
 
Coverslip preparation: 
Coverslips were washed several times with 70 % EtOH, dried and left under the UV light 
in the hood for sterilization. Then they were coated appropriately 
 
Coating of coverslips / cell culture dishes with laminin 111 or 211:  
Dishes were washed once with ddH2O. Laminin 111 or 211 (10 µg/ml in ddH2O) was 
added and incubated for at least 3 h at 37° C. The unbound laminin 111 or 211 was 
removed and medium was added for 15 minutes. The medium was aspirated and the cells 
seeded. 
 
 
Induction of process retraction of primary SCs upon treatment with 
lysophosphatidic acid (LPA) 
 
Wild-type and mutant (P0) primary SCs were isolated as described above and plated on 
either laminin 111 or 211.  
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Next day, they were split in six well plates suitable for time lapse video-microscopy. The 
following day the growth medium was replaced by growth medium containing 10 µM 
LPA (lysophosphatidylic acid). On two individual wells, five different areas were 
monitored with a 10 x objective. Phase contrast images were taken every 30 seconds for a 
total of 30 minutes. The retraction of processes from free-growing SCs that showed a 
bipolar shape was measured using the ImageJ software. 
 
Measuring the migration of primary SCs growing on laminin 
 
Wild-type and P0-Cre/cKO primary SCs were isolated as described above and plated on 
either laminin 111 or 211. Next day the cells were split in six well plates suitable for time 
lapse video-microscopy. Six hours later, after making sure the cells had attached, the time 
lapse analysis was started. Phase contrast images were taken every 30 minutes for 24 h in 
total. The migration of free growing bi-polar shaped SCs was measured by tracking their 
nuclei using the multitracker plugin for ImageJ. 
 
Image acquisition / microscopes 
 
A Zeiss laser scanning microscope (LSM) 510 microscope was used for taking 
immunfluorescent images from cells and teased nerve fibers. Digital images were 
processed using Adobe Photoshop, Adobe Illustrator and ImageJ software. 
 
Time-lapse video microscopy was performed using a motorized AxioObserver Z1 
microscope coupled to AxioCam MRm (Carl Zeiss MicroImaging, Inc.) and equipped 
with phase contrast optics. During the analysis the cells were cultivated in a PM S1 
incubator (Carl Zeiss MicroImaging, Inc.) at 37°C and 5% CO2, pictures were acquired 
using the “mark and find” module of AxioVision 4.8.1 image analysis software. Images 
were processed with Zeiss AxioVision 4.8.1 image analysis software (Carl Zeiss 
MicroImaging, Inc.) and further analyzed using open source software ImageJ (Rasband, 
W.S., ImageJ, NIH) for manual tracking of migrating cells. 
 
Digital images were processed using Adobe Photoshop, Adobe Illustrator and ImageJ 
(Rasband, W.S., ImageJ, NIH) software. 
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Animal husbandry 
 
To reveal functions of plectin essential for myelinating SCs, a new mouse line was 
generated, by mating mice carrying floxed plectin alleles (Ackerl et al., 2007) with 
myelin protein zero (P0)–Cre mice (from L. Feltri & L. Wrabetz, San Raffaele Scientific 
Institute, DIBIT, Milano, Italy), to selectively ablate the whole set of plectin isoforms 
expressed in myelinating SCs (Feltri et al., 1999). Preliminary analyses showed that the 
resulting P0–Cre/cKO mice selectively lack plectin in myelinating SCs (data not shown), 
live to adulthood, and are fertile. Thus, they could be considered as an ideal tool to study 
the role of plectin in peripheral nerve cell function and regeneration. The P0–Cre/cKO 
mouse line has been back–crossed to the C57BL/6 background to congenicity. 
 
 
Mice were kept under standard housing conditions at the animal facility of the 
Department of Molecular Cell Biology at the Vienna Biocenter. All experiments 
involving animals were performed in accordance with Austrian Federal Government laws 
and regulations. 
 
Rats were purchased from Institut für biomedizinische Forschung, Abteilung für 
Labortierkunde und Genetik Himberg.. 
 
 
 
Common buffers and solutions 
 
5 x SDS-sample buffer: 
- 400 mM  Tris/HCl 
- 10 % (v/v)  SDS 
- 50 % (v/v)  Glycerol 
- 500 mM  DTT 
- 0.1 %  Bromphenolblue 
- pH 6.8 
 
10 x PBS: 
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- 81.8 g NaCl 
- 2.01 g KCl 
- 2.04 g KH2P04 
- 11.3 g K2HP04 
pH 7.4; ddH2O to 1000 ml  
 
PBS - T: 
PBS containing 0.05 % Tween-20 
 
TB Medium: 
- 1.2 % Tryptone or Peptone  
- 2.4 % Yeast extract 
- 0.4 % Glycerol 
autoclaved and mixed with a sterile phosphate buffer  
- 17 mM KH2P04 
- 72 mM K2HP04 
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Antibodies 
Antibody name  Antibody Antigen/ Dilution Dilution Dilution Vendor/ 
Clone name type Epitope WB IF IP  Reference 
         
         
Plectin 1 polyclonal  Exon 1 encoded 1:500     (Abrahamsberg 
et al., 2005) 
  rabbit  amino acids         
P1a polyclonal  Exon 1a encoded 1:400     (Rezniczek et 
al., 1998) 
  rabbit  amino acids         
P1c polyclonal  Exon 1c encoded 1:400     (Fuchs et al., 
2009) 
  rabbit  amino acids         
P1f polyclonal  Exon 1f encoded 1:1.000     (Rezniczek et 
al., 2007) 
  rabbit  amino acids         
#9 polyclonal Exon 9-12 1:3.333     (Andrä et al., 
2003) 
  rabbit amino acids         
10F6 monoclonal plectin rod 1:5  undiluted (Wiche et al., 
1984) 
 mouse       
beta-DG monoclonal synthetic peptide 1:100 1:20   Novocastra 
43DAG1/8D5 mouse c-terminus of 
human β-DG 
        
beta-DG rabbit β-dystroglycan        (Ilsley et al., 
2001) 
#1709 sera phosphopeptide   1:20   
#1710         1:20   
DP116 monoclonal  1:100 1:20   Novocastra 
NCL-DYS 2 mouse           
Integrin beta4  polyclonal human integrin  1:200 1:50 1 µg per  Santa Cruz 
(C-20) goat β4C terminus   100 µg   
sc-6628         protein   
Vimentin goat   1:10.000 1:400   Taub 
Actin monoclonal   synthetic peptide 1:500 1:100   sigma-aldrich 
ac40 mouse  c-terminal         
Caveolin rabbit   1:10.000     
Utrophin rabbit aa 3204-3433 of 
human utrophin 
1:5.000     (Winder and 
Kendrick-
Jones, 1995) 
GFAP (GA5) monoclonal  purified pig  1:1.000 1:300 1:50 cell signaling  
  mouse  GFAP         
GAPDH rabbit  synthetic peptide 1:5.000 1:200   sigma-aldrich 
g9545    aa 314-333 mouse 
 GAPDH 
        
beta III tubulin polyclonal  Aa 441-450 1:1.000 1:100   sigma-aldrich 
  rabbit           
GST monoclonal Purified 
recombinant 
1:1.000     Sigma-Aldrich 
(GST-2) mouse GST         
α−tubulin monoclonal    1:6.666     Sigma-Aldrich 
B-5-1-2 mouse c-terminus         
α − dystroglycan monoclonal  rabbit skeletal  
muscle membrane 
1:2.000     Millipore 
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IIH6C4 mouse preparation Clone 
IIH6C4 
        
δ−Sarcoglycan rabbit   1:4.000     G. Piluso 
              
penta HIS monoclonal    1:1.000     Qiagen 
  mouse           
p75 NGFR polyclonal GST-tagged NGF  1:1.000 1:100   Millipore 
 Cat. #AB1554 rabbit  receptor p75         
DRP2 (2164) rabbit synthetic peptide 
aa 947–957 
  1:300   (Sherman et 
al., 2001) 
CASPR 2 rabbit     1:500   (Denisenko-
Nehrbass et 
al., 2003) 
EZRIN rabbit human ezrin  1:100  Upstate 
  aa 479-498      Biotech 
SL-51 rabbit      1:1.000   J. A. Girault 
E-Cadherin monoclonal   Human E-Cadherin   1:100   BD Transduct. 
 36/E-Cadherin mouse  aa. 735-883       Laboratories 
#21 rabbit Plectin rod   1:200   G. Wiche 
  sera           
#46 rabbit Plectin rod  1:400 1:40 G. Wiche 
 sera      
GFP monoclonal partially purified   1:40 Roche 
clones 7.1 and 13.1 mouse recombinant 
Aequorea victoria 
GFP 
      diagnostics 
       
       
Secondary ABs:             
         
AP anti-rabbit IgG goat   1:5.000      Jackson Lab. 
AP anti-mouse IgG goat   1:5.000      Jackson Lab. 
HRP0 anti-mouse IgG goat   1:10.000    Jackson Lab. 
HRP0 anti-mouse IgM donkey   1:50.000    Jackson Lab. 
HRP0 anti-rabbit IgG goat   1:20.000    Vector Labs 
HRP0 anti-goat IgG donkey   1:50.000    Jackson Lab. 
         
         
Secondary ABs: IF        
         
RRX anti-rabbit IgG donkey     1:200   Jackson Lab. 
Cy2 anti-rat donkey     1:200   Jackson Lab. 
Cy5 anti rabbit donkey   1:500  Jackson Lab. 
Cy5 anti-rat donkey     1:500   Jackson Lab. 
Cy5 anti-mouse donkey   1:500  Jackson Lab. 
RRX anti-mouse donkey     1:200   Jackson Lab. 
RRX anti-rat donkey   1:200  Jackson Lab. 
Alexa 488 anti goat donkey     1:800   Molecular  
            Probes 
Alexa 488 anti-rabbit donkey   1:1.000  Molecular 
            Probes 
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List of chemicals: 
 
Reagent     Vendor       Article number 
 
30 % Acrylamide mix (29:1)   Gerbu    1108 
Acetic acid     Merck    100063 
Agar      Gerbu    1340 
AgNO3     Fluka    85228 
Ammoniumpersulfate (APS)   Serva    13375 
Ampicilin     Gerbu    1046 
BCIP (X-Phos)    Gerbu    71290 
bovine pituitary extract   PromoCell   C-24110 
bovine serum albumin (BSA)  Gerbu    1063 
Bromphenolblue-Solution   Sigma-Aldrich  B7021 
Collagenase Typ I    Gibco    17100-017 
Coomassie blue R250    Gerbu    1097 
Deoxycholat     Sigma-Aldrich  06750 
Dispase Typ II    Gibco    17105-041 
Dithiothreitol (DTT)    Gerbu    1008 
DMEM-F12     Gibco    11320-074 
Dimethylformamid (DMF)   Loba    402480 
Dimethylsulfoxid (DMSO)   Fluka    41640 
DNAse I     Roche    104159 
DMEM     Gibco    52100-039 
EGTA      Sigma-Aldrich  E-4378 
Ethanol     Merck   100983 RdH 32221 
Ethylenediaminetetraacetic acid (EDTA)  Gerbu    1034 
Fetal calf serum (FCS)   Sigma-Aldrich  F-7524 
FGF 2 (basic fibroblast growth factor) PromoCell   C-24110 
Forskolin     Calbiochem   344270  
Fungizon     Gibco    15290-026 
Gentamycin     Gibco    15710-049 
Glucose     Merck    8346 
Glutathion-reduced    Sigma-Aldrich  G4251-504  
Glutathion sepharose beads   GE-Healthcare  17-0756-01 
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Glycerol     Gerbu    2006 
Glycine     Gerbu    1023 
Formaldehyde     Merck    C3914003 
Hepes      Gerbu    1009 
Heregulin-beta-1    R&D Systems   396-HB-050 
Hoechst dye (#33258)   Hoechst   382061 
Hydrochloric acid (HCl)   Merck    100317 
Imidazol     Fluka    56750 
IPTG      Gerbu    1010 
Isofluran (Isoflo)    Abbott    34480VA 
Isopropanol     Merck    109634 
K2HP04     Fluka    60356 
KCl      Loba    58648 
KH2P04     Fluka    60230 
Laminin-1     Sigma-Aldrich  L2020    
L-glutamine     Gibco    25030-024 
Lysophosphatidylic acid (LPA)   Cayman   62215 
Lysozyme     Gerbu    1603 
Merosin     Chemicon   CC085 
Methanol     Merck   106009-RdH 32213 
MgCl2      Fluka    63072 
Na2CO3     Loba    70598 
Na2S2O3*5H2O    Merck    6512 
Na2HP04 Disodiumhydrogenphosphate  Fluka     71645 
NaH2P04 Sodiumdihydrogenphosphate  Fluka    71506   
NaCl      Gerbu    1112 
Natriumazid (NaN3)   Fluka    71290 
NBT      Sigma-Aldrich  N-6876 
NP-40 (nonident P-40)   Sigma-Aldrich  I-3021 
Paraformaldehyde (PFA)   Fluka    47629   
Phosphate buffered saline (PBS)  Gibco    21300-074  
Penicilin/Streptomycin   Gibco    15070-22 
Peptone     Gibco    30392 
Phenylmethanesulfonylfluoride-(PMSF) Sigma-Aldrich  P-7626 
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Phosphatase Inhibitor Cocktail 3  Sigma-Aldrich  P0044  
Phosphatase Inhibitor Cocktail 2  Sigma-Aldrich  P5726 
Ponceau S     Sigma-Aldrich  P3504 
Protease inhibitor cocktail complete mini Roche    11836153001 
Protein-G Agarose      Pierce    20398 
RNAse A     Roche     10109142001 
Skim milk powder    Gerbu    1602 
Sodium bicarbonate    Gibco    043-5080 
Sodiumdodecylsulfate (SDS)   Sigma-Aldrich  L-4509 
Sodium hydroxide solution (NaOH)  Gerbu    2020 
Sodium pyrovate    Sigma    P-5280 
Sucrose     Gerbu    1366 
Sulfonsalicylic acid    Fluka    86195 
TEMED     Serva    35925 
Trichloracetic acid (TCA)   Sigma-Aldrich  T-4885 
Tris-X      Gerbu    1018   
Triton-X-100     Gerbu    9002-93-1 
Trypsin     Gibco    15090-046 
Tween-20     Gerbu    2001 
Urea      Gerbu    1044 
Yeast-extract     Gerbu    1133 
 
Dishes/flasks (cell culture) were purchased from NUNC  
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Abstract 
 
Plectin is a large (~ 500 kDa) and versatile cytoskeletal linker protein which belongs to a 
protein family called plakins or cytolinkers. It is able to bind to all major cytoskeletal 
filament systems: actin (micro)filaments, intermediate filaments and microtubules. 
Furthermore, plectin binds to cell-matrix junctional complexes, thus confering 
mechanical stability not only to single cells but whole tissues. In this diploma thesis, 
plectin’s roles in Schwann cells (SCs) were investigated. SCs are the glia cells of the 
peripheral nervous system (PNS), where they play essential roles in electrically isolating 
the axon, connecting the axons to the surrounding basal membrane and transducing 
signals from the extracellular matrix (ECM) and the axon. 
 
Performing immunoblotting experiments and immunofluorescence microscopy I could 
demonstrate the  expression of plectin isoforms 1, 1c and 1f in SCs in sciatic nerve as 
well as in primary SCs. Results from co-immunoprecipitation (Co-IP) experiments 
suggested that in SCs plectin interacts with integrin α6β4 and the dystrophin-glycoprotein 
complex (DGC), two laminin 211 binding receptor complexes in the abaxonal SC 
membrane. Furthermore, I have shown that plectin binds to sciatic nerve vimentin via co-
IP and overlay experiments. Using a mouse model with a SC-specific conditional plectin 
knockout (P0-Cre/cKO) I could investigate the effects of plectin ablation on SC 
functions. I found that protein expression levels of constituents of DGC as well as of the 
integrin α6β4 complex were altered in P0-Cre/cKO sciatic nerves. Furthermore I could 
detect changes in the subcellular distribution of α- and β-dystroglycan (members of the 
DGC) in P0-Cre/cKO sciatic nerve which possibly resulted from increased cleavage of β-
dystroglycan by a matrix metalloprotease. No changes in the compartmentalization and 
molecular differentiation of myelinating SCs could be observed in P0-Cre/cKO nerve 
fibers by immunofluorescence microscopy. Phenotypic analysis of primary SCs derived 
from sciatic nerve of wild-type and P0-Cre/cKO mice demonstrated reduced motility of 
plectin-null SCs growing on laminin 211. Furthermore P0-Cre/cKO SCs showed 
increased process retraction upon treatment with the signaling molecule lysophosatidic 
acid (LPA). 
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Zusammenfassung 
Plectin ist ein etwa 500 kDa großes und sehr vielseitiges cytoskelettäres Linkerprotein. 
Es ist ein Mitglied der Plakine oder Cytolinker. Plectin kann an alle drei cytoskelettären 
Filament Systeme binden: das Aktin Filamentsystem, das Intermediärfilamentsystem und 
Mikrotubuli. Des Weiteren verleiht Plectin auch ganzen Geweben Stabilität indem es an 
Zell-Matrix Kontaktstellen bindet. Im Zuge dieser Diplomarbeit wurden Plectins Rollen 
in Schwann Zellen (SZ) untersucht. SZ sind die Glia Zellen des peripheren Nerven-
systems (PNS). Zu ihren Funktionen gehören die elektrische Isolation des Axons, sowie 
die mechanische Verbindung des Axons mit der umgebenden Basalmembran und die 
Signaltransduktion zwischen Axon und extrazellulärer Matrix.  
 
Mittels Immunoblotting-Analyse und Immunfluoreszenz-Mikroskopie konnte ich die 
Expression der Plectin-Isoformen 1, 1c und 1f sowohl in SZ des Ischiasnervs als auch in 
primären SZ zeigen. Hinweise auf zwei stabilisierende Verbindungen, bei denen Plectin 
zwei Laminin 211-Rezeptor-Komplexe [Dystrophin-Glycoprotein-Komplex (DGK) und 
Integrin α6ß4] an das Intermediärfilamentsystem koppelt, ergaben sich durch Co-
Immunopräzipitation und Protein-Overlay-Experimente. Mithilfe einer Mauslinie, mit 
einem konditionellen Plectin-Knockout in SZ (P0-Cre/cKO), konnte ich die Effekte von 
fehlendem Plectin auf die Funktion von SZ in situ untersuchen. Ich konnte 
Veränderungen in der subzellulären Verteilung von α- und ß-Dystroglycan (Mitglieder 
des DGK) in Ischiasnerven aus P0-Cre/cKO Mäusen beobachten. Diese Veränderungen 
wurden vermutlich durch den Verlust der Verankerung des DGK am Intermediär-
filament-System und der daraus resultierenden verstärkten Spaltung von ß-Dystroglycan 
durch Matrix-Metalloproteinasen verursacht. Immunfluoreszenz-Mikroskopie von 
gezupften P0-Cre/cKO Nervenfasern zeigte keine Veränderungen in der Kompart-
mentalisierung von myelinisierenden SZ oder des Axons. Möglicherweise wurde der 
Verlust von Plectin durch verstärkte Expression wichtiger Proteine des DGK und des 
Integrin α6ß4 Komplexes kompensiert. Solche verstärkten Expressionen konnte ich durch 
semiquantitative komparitive Immunoblotting-Analysen zeigen. Die phenotypische 
Analyse primärer SZ, isoliert aus Ischiasnerven von Wildtyp und P0-Cre/cKO Mäusen, 
zeigte reduzierte Motilität von Plectin-defizienten SZ. Zusätzlich konnte ich bei Plectin 
defizienten-SZ eine erhöhte Retraktion von Fortsätzen nach Behandlung mit dem 
Signalmolekül Lysophosphatidylsäure beobachten. 
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